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CHAPTER I 
 
INTRODUCTION 
 
Statement of Problem 
 
More than 40,000 individuals are diagnosed with head and neck cancer (HNC) in the 
United States each year (American Cancer Society, 2012).  Because the head and neck are 
such highly visible areas, disfigurement resulting from the disease and treatment often 
occurs in these patients (Katz, Irish, Devins, Rodin, & Gullane, 2000). In addition to disease 
and treatment related disfigurement, patients may also experience dysfunction if this 
disease and its treatment alter the way they speak, eat, and move. The potential for 
disfigurement and functional difficulties in this population makes them particularly 
susceptible to body image disturbance. Body image has been described in the HNC patient 
population as a highly complex phenomenon that includes an individual’s perceptions of his 
body as a physiological, psychological, and social entity (Dropkin, 1989). It has also been 
described as a complex, multidimensional phenomenon consisting of one’s attitudes, 
perceptions, and experiences pertaining to one’s own physical appearance (Cash & Fleming, 
2002). Body image is influenced by dissatisfaction with appearance, psychosocial distress, 
and functional decline (Cash & Fleming, 2002). Disturbed body image has cross-sectionally 
been associated with depressive symptoms in this population (Dropkin, 2001; Fingeret, 
Vidrine, Reece, Gillenwater, & Gritz, 2010; Katz, Irish, Devins, Rodin, & Gullane, 2003). The 
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problem of interest for this dissertation study is body image in patients who have 
undergone treatment for HNC. 
 
Significance of the Issue and the Study 
 
Significance of the issue to society  
  HNC demographics. Approximately 40,000 individuals in the United States are 
diagnosed with HNC annually (American Cancer Society, 2012). Head and neck cancers 
occur in the oral cavity, pharynx, larynx, paranasal sinuses, and salivary glands (Howlader et 
al., 2011). The majority of head and neck cancers are squamous cell carcinomas that 
originate from the mucosal lining of these areas (Howlader et al., 2011). HNC is strongly 
associated with certain environmental and lifestyle risk factors, including tobacco use, 
alcohol consumption, and certain strains of viruses (Ridge et al., 2008). It is currently more 
common in men and older adults (NIH, 2011). The demographics of individuals with HNC are 
changing due to the human papillomavirus (HPV) emerging as a causative factor 
(Chaturvedi, Engels, Pfeiffer, Hernandez, Xiao, Kim, Jiang, Goodman, Sibug-Saber, Cozen, 
Liu, Lynch, Wentzensen, Jordan, Altekruse, Anderson, Rosenberg, & Gillison, 2011). In the 
United States, the incidence of HPV associated tumors is increasing while the incidence of 
tumors caused by alcohol and tobacco use is decreasing (Chaturvedi, et al., 2011). 
Interestingly, individuals with HPV associated tumors have higher response rates to 
treatment compared to those with HPV-negative tumors (Lindquist, Romanitan, 
Hammarstedt, Nasman, Dahlstrand, Lindholm, Onelov, Ramqvist, Ye, Munck-Wikland, & 
3 
Dalianis, 2007). The increased survival rates and relative younger age of these individuals 
also increases the length of time that these survivors will potentially experience late-effects 
of HNC treatment. Considering all races and tumor locations, the five-year relative survival 
rate is 57% and the ten-year relative survival rate is 47% (Howlader et al., 2011). It is 
estimated that there are currently more than 500,000 survivors of HNC living in the United 
States (Howlader et al., 2011).  
HNC treatment: disfigurement, potential for body image disturbance, and 
dysfunction. Disfigurement in patients with HNC may be caused by surgery or radiation 
therapy. Surgical excision of the tumor may involve removal of nerves, vasculature, soft 
tissue, and bone (NCI, 2012). Extensive resections, including mandibulectomy, glossectomy, 
and laryngectomy may result in highly visible surgical incisions, changes in facial shape, and 
alterations in the ability to elicit facial expressions critical to normal non-verbal 
communication (NCI, 2012). Patients may require bone grafting, skin grafting, free or 
pedicle flaps, and metal hardware for reconstruction (NCI, 2012). Although these 
techniques may lessen the disfigurement, they are potentially disturbing to patients. 
Surgical procedures that are particularly psychologically intrusive include total 
laryngectomy, orbital exenteration, and midface resection that extirpates the nose (NCI, 
2012).  
Although less well studied, radiation therapy may also affect physical appearance. 
Radiation therapy may result in tissue swelling (lymphedema) and fibrosis (NCI, 2012). 
These processes affect normal tissue contours causing a change in facial features and facial 
asymmetry.  In one study 75.3% of patients (n=81) had some form of late-effect 
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lymphedema (Deng, Ridner, Dietrich, Wells, Wallston, Sinard, et al., 2012). Of those, 39.4% 
(24/61) had only external lymphedema, and 50.8% (31/61) had both internal and external 
lymphedema (Deng et al., 2012). Radiation may result in alteration in skin texture, color and 
elasticity (NCI, 2012). This is very prominent in African Americans where radiation may 
result in dramatic discoloration within the radiation port. Radiation may also result in 
salivary gland hypofunction and subsequent development of dental carries (NCI, 2012). A 
high percentage of patients with radiation induced dental carries will require dental 
extraction (NCI, 2012). Loss of teeth may lead to marked alterations in appearance. 
Although the use of dentures may ameliorate this problem, hyposalivation leads to 
decreased use of dentures due to discomfort and poor retention (NCI, 2012).  
 The second major category of tumor and treatment-related effects that may cause 
body image disturbance is alterations in function (dysfunction). In the head and neck 
population, dysfunction may be grouped into the following: 1) general functional deficits 
(weakness and fatigue), 2) head and neck specific functional loss (speech, swallowing, sight, 
and smell) and 3) musculoskeletal impairment involving the neck, shoulders, and jaw. 
Although there is limited literature assessing the impact of function on body image, it may 
be hypothesized that all three types of functional deficiencies may result in an adverse 
impact on body image. For example: patients with generalized weakness may have difficulty 
with routine daily activities. Patients who are unable to speak and communicate clearly may 
experience a loss of employment and social isolation. Patients who cannot swallow often 
require a feeding tube which may dramatically impact  body image. Patients with decreased 
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range of motion in their neck may not be able to put on a coat without assistance. All of 
these scenarios may result in altered body image and associated sequellae. 
 Although the data is limited, several factors have been shown to moderate the 
effect of disfigurement and dysfunction on body image in HNC patients. Moderators can be 
broadly classified as patient related factors, social or relational factors, and environmental 
factors. The personal characteristic of social self-efficacy has been shown to mitigate the 
association between facial disfigurement and social isolation (Hagedoorn & Molleman, 
2006). Age is also a moderator of psychosocial distress in response to disfigurement. 
Younger patients (< 65 years old) with HNC tend to be more concerned about their 
appearance (Katre, Johnson, Humphris et al., 2008; Katz, Irish, Devins, et al., 2003). In 
women, social support has been shown to moderate the impact of disfigurement on 
wellbeing (Katz et al., 2003). It should be noted that this effect was not noted in men (Katz 
et al., 2003). 
Summary of social significance. Patients with HNC have a high potential for 
disfigurement and body image disturbance given the visible location of the disease and 
targeted treatments. Patients not only experience disfigurement, but also potential 
dysfunction if the way they speak, eat, and move is altered by this disease and its 
treatment. The significant impact of facial disfigurement and dysfunction in patients with 
HNC can be attributed to the importance of the facial region to a person’s identity, ability to 
communicate, ability to achieve success in interpersonal relationships, and to a person’s 
body image (Katz et al, 2000). Because body image disturbance in patients with HNC has 
been associated with anxiety, depression, and perceived social isolation in cross-sectional 
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studies, it is particularly important that body image be described more thoroughly in this 
population.  
Costs to individuals with HNC related disfigurement.  
Employment. Many individuals with a visible disfigurement feel uncomfortable 
returning to their previous jobs after treatment because it requires interacting with co-
workers and clients (Hu, Cooke, & McCarthy, 2009). Negative or discomforting responses to 
facial disfigurement in the work place have been consistently documented (Tartaglia, 
McMahon, West, & Belongia, 2005). Avoidance of individuals with facial disfigurement has 
also been well documented (Rumsey, Bull & Gahagan, 1982 & Houston & Bull, 1994). 
Although many older individuals may have the option to retire after treatment, younger 
individuals with HNC related disfigurement may not have this option (Verdonck-de Leeuw, 
van Bleek, Leemans, & de Bree, 2010). Although disfigurement is covered under the 
Americans with Disabilities Act, individuals seeking new employment opportunities 
following treatment may also have difficulty (National Network, 2012). In one study of 
disfigurement and employment, recruiters were more likely to have a negative reaction to 
physical disability and an even greater negative reaction to facial disfigurement (Stevenages 
& McKay, 1999). Because many patients with HNC related disfigurement also have 
functional deficits following treatment, finding new employment represents an even 
greater challenge.  
Social. Individuals with HNC related disfigurement may face social challenges not 
only during treatment but during the recovery phase as well. Many individuals with a visible 
cancer related disfigurement report a changed relationship with their spouse as a result of 
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their disfigurement (Manne & Badr, 2008). Rates of psychological distress among partners 
of HNC patients, for example, are higher than any other type of cancer (Manne & Badr, 
2010). Social difficulties for individuals with cancer related disfigurement also extend 
beyond the spouse or partner. Individuals in this population have reported high levels of 
isolation from pre-cancer social networks (Hagedoorn & Molleman, 2006 & Gamba, 
Romano, Grosso, Tamburini, Cantu, Molinari, & Ventafridda, 1992). 
 Summary of costs to individuals. The cost of HNC related disfigurement and possible 
body image disturbance have the potential to affect patients on both financial and social 
levels. If a patient with HNC feels unable to return to work following treatment, whether 
due to body image disturbance or to the negative reactions of others, then financial 
hardship can ensue. These same factors may also affect the social relationships of patients 
with HNC causing isolation from pre-cancer relationships and support systems.   
Significance of the issue to healthcare   
System utilization and costs to insurers. Body image in individuals with HNC related 
disfigurement is particularly important to the healthcare system with respect to additional 
costs incurred by insurers. Individuals with cancer related disfigurement, particularly those 
who have disturbed body image, utilize psychological and cosmetic support services 
(Watson, 1983; Bronheim, Strain, & Biller, 1991; Macgregor, 1989). There is currently no 
data that describes the specific financial impact on the insurance industry from patients 
with HNC related disfigurement who have disturbed body image. It would seem reasonable, 
however, that if these patients seek psychological and cosmetic support services to improve 
their body image and overall psychological state, an additional expense would be incurred. 
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Although there is no specific data in the HNC patient population, one study found that only 
29% of breast cancer survivors who had undergone a mastectomy had received 
reconstructive surgery (Kruper, Holt, Xu, Duan, Henderson, Bernstein, & Ellenhorn, 2011). 
The study found that patients with private insurance were 10 times more likely to undergo 
reconstruction than patients without private insurance (OR 9.95, 95% CI 8.46-11.70) (Kruper 
et al., 2011).  Furthermore, patients without insurance and who may not have the resources 
to seek psychological assistance represent an additional cost to the healthcare industry 
through the possibility of uninsured emergency psychiatric care.  
Summary of significance to healthcare. Body image disturbance has the potential to 
represent additional costs to the healthcare system in terms of patients who have 
experienced HNC related disfigurement.  
Significance of the issue to the discipline of nursing  
            Frequent interaction. Body image in patients with HNC related disfigurement is 
significant to the discipline of nursing for several reasons. Nurses are often the first point of 
contact for oncology patients experiencing any type of difficulty throughout the disease 
trajectory (MacDonald, 1997).  Because of their frequent interaction with patients, nurses 
are uniquely positioned to address psychosocial concerns like body image in patients with 
cancer related disfigurement (Price, 1995; Sheldon, Harris, & Arcieri, 2012). “Although 
oncology nurses are not therapists, they do provide supportive care, assess patient 
psychosocial concerns, and pursue further assessments for significant concerns or changes 
in functioning” (Sheldon, Harris, & Ariceri, 2012). 
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Patient education. Oncology nurses and nurse practitioners are often responsible for 
patient education before, during, and after treatment (Sheldon, Harris, & Arcieri, 2012). As 
patient educators, they should be familiar with the multidimensional aspects of body image, 
particularly in patients with cancer-related disfigurement. This knowledge is useful in 
preparing the patient for treatment that has the potential to cause disfigurement as well as 
addressing concerns that may arise prior to treatment. Oncology nurses and nurse 
practitioners can also provide continued education, as necessary, about body image in the 
post-treatment recovery phase. 
            Assessment and intervention. Continued psychosocial assessment of the patient 
throughout treatment and recovery is necessary as changes in appearance occur for a 
myriad of disease and treatment related reasons. By having adequate knowledge of body 
image and its implications, the nurse will be able to assess changes in body image.  Nurses 
and nurse practitioners can also offer strategies for coping with head and neck cancer-
related disfigurement (Bonanno & Esmaeli, 2012). Psychosocial care is part of holistic 
nursing (Sheldon, Harris, & Ariceri, 2012). Prompt detection of changes in body image is 
part of holistic care for the patient with head and neck cancer-related disfigurement. 
“Oncology nurses can be visible and articulate as advocates for timely and effective 
assessment of psychosocial concerns in cancer care” (Sheldon, Harris, & Ariceri, 2012). 
Oncology nurse practitioners will not only be able to assess body image issues, but as 
patient care providers, they will also be part of the team treating these issues in this 
population.  
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 Summary of significance to nursing. Oncology nurses and nurse practitioners play a 
significant role in early assessment, educating patients, and facilitating effective coping for 
patients who have experienced HNC related disfigurement and possible body image 
disturbance.     
Summary of overall significance   
As a result of disease and treatment related variables, many patients with HNC 
experience some form of disfigurement and subsequent body image disturbance.  The 
potential implications of living with cancer-related disfigurement and body image 
disturbance can include psychological, social, and monetary costs to the individual as well as 
increased healthcare system utilization and increased demands of nursing care. Because of 
the potential for significant disfigurement and dysfunction associated with HNC and its 
treatment, as well as the associations with anxiety, depression, and perceived social 
isolation, it is particularly important that body image be described more thoroughly in this 
population.  
 
Purpose of the Study 
 
 The purpose of this study is to examine body image, disfigurement, depressive 
symptoms, and neck-related functional status in adults who have been treated for HNC. 
This study also examines the relationships among the previously stated variables. Specific 
aims for this study include:  
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1. To examine the trajectory of perceived body image in adults with HNC before and after 
treatment and throughout the first year of recovery.  
2. To examine the nature of the relationship between body image and cancer-related 
disfigurement in adults with HNC before and after treatment and throughout the first year 
of recovery.  
3. To examine the nature of the relationship between body image and depressive symptoms 
in adults with HNC before and after treatment and throughout the first year of recovery.  
4. To examine the relationship between body image and neck-related functional status in 
adults with HNC before and after treatment and throughout the first year of recovery.  
 
Research Questions 
 
This study addresses the following research questions:  
1. What is the trajectory of perceived body image in adults with HNC before and after 
treatment and throughout the first year of recovery?  
2. What is the nature of the relationship between cancer-related disfigurement and body 
image in adults with HNC before and after treatment and throughout the first year of 
recovery? 
3. What is the nature of the relationship between body image and depressive symptoms in 
adults with HNC before and after treatment and throughout the first year of recovery? 
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4. What is the nature of the relationship between body image and neck-related functional 
status in adults with HNC before and after treatment and throughout the first year of 
recovery? 
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CHAPTER II 
 
LITERATURE REVIEW 
 
History of the Problem of Interest 
 
“Visible disfigurement, particularly facial disfigurement, presents psychological and 
social challenges to the individual who has to cope with an appearance that is obviously 
different, hard to conceal, and subject to social stigma” (Bradbury, 2012).  Adverse 
reactions to visible disfigurement have been well documented throughout history  (Weiser, 
1963 in Shaw 1981; Babalola, 1978 in Shaw 1981; Dehragoda, 1978 in Shaw 1981; Shaw, 
Humphreys, McLoughlin, & Shimmin, 1980 in Shaw, 1981 ).  
Patients with HNC are a key population that potentially experience disfigurement. 
“Early surgical techniques were radical, removing both the cancer and surrounding healthy 
tissue” (American Society of Clinical Oncology, 2011). Advances in surgical techniques for 
head and neck cancers have improved cosmetic results in some patients (American Society 
of Clinical Oncology, 2011). “In the 1970s, the utilization of free flaps to reconstruct defects 
of the oral cavity increased” (Medscape, 2012). “In the late 1980s and early 1990s, the use 
of osteocutaneous free flaps to reconstruct mandibular defects was advanced” (Medscape, 
2012). Although advances in surgical techniques have been made, aggressive treatment 
modalities, post-operative complications, and late effects of treatment can still significantly 
contribute to the disfigurement experienced by these patients (Katz, Irish, Devins, Rodin, & 
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Gullane, 2000). The current literature shows that patients with HNC related disfigurement 
often experience body image disturbance (Rumsey, Clarke, White, Wyn-Williams, & Garlick 
2004).  
 
Analysis of Relevant Literature 
 
Descriptive cross-sectional design  
Cross-sectional designs have been frequently used to study body image disturbance 
or disfigurement in the HNC patient population as shown in Table 1 (Fingeret, Vidrine, 
Reece, Gillenwater, & Gritz, 2010; Katre, Johnson, Humphris, Lowe, & Rogers, 2008; 
Hagedoorn & Molleman, 2006; Katz, Irish, Devins, Rodin, & Gullane, 2003). The timing of 
assessment, however, has varied among studies. Only one of the cross-sectional studies 
examined body image prior to treatment (Fingeret et al., 2010). The other cross-sectional 
studies examined disfigurement or problems with appearance and other psychosocial 
variables at a post treatment time point. This assessment time point, however, was not 
standardized in any of these studies. Length of time since treatment varied as much as 14 
years among patients in two of the examined studies (Katre et al., 2008 & Katz et al., 2003).   
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Table 1 
Comparison of cross-sectional studies 
Study/Author Purpose Design Variables & 
Instruments 
Relevant Findings Strengths & 
Weaknesses of 
Design 
Multi- 
dimensional  
analysis of body 
image concerns 
among newly 
diagnosed 
patients with oral 
cavity cancer. 
(Fingeret et al., 
2010) 
1. To 
provide 
novel data 
about 
multiple 
dimension
s of body 
image 
through 
the use of 
existing 
measures.  
2. To 
evaluate 
relationshi
ps 
between 
body 
image and 
key 
demograp
hic, health 
behavior, 
medical, 
and 
psychosoc
ial var 
iables.  
Cross-
sectional.  
75 newly 
diagnosed 
patients 
with oral 
cancer  
(56% male, 
44% 
female, 
60% 
Caucasian) 
completed 
self-report 
questionna
ires  prior 
to surgical 
treatment 
and a 
structured 
clinical 
interview.  
Study 
conducted 
in the 
United 
States. 
Body Image:  
1. BIS 
2. ASI-R 
3. BSS 
4. FNAES 
5. HNS-AP 
6. Structured 
clinical 
interview 
 
Psychological 
distress: BSI-18 
1. 77% (n=58) identified 
current and/or future 
appearance related concerns.  
2. 36% (n=20) reported at least 
moderate levels of distress 
associated with thoughts about 
appearance.  
3. No gender differences found 
on any of the body image 
measures.  
4. A significant positive 
correlation (p<.05) found 
between each of the body 
image measures with the 
exception of the ASI-R and BIS 
(.14) and the ASI-R and BSS 
(.09).  
5. With the exception of the 
ASI-R, all other measures were 
positively skewed, suggesting 
that as a whole, scores 
reflected relatively low levels 
of current body image 
concerns.  
6. Multivariate analyses 
indicated that while controlling 
for effects of other variables, 
depression was the strongest 
and most consistent predictor 
of body image outcomes across 
the measures (p<.01).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strengths:  
1. Patients assessed 
at approximately 
the same point in 
the 
disease/treatment/r
ecovery trajectory 
(after diagnosis but 
prior to surgery).   
2. Compared several 
body image 
instruments in one 
population.  
 
Weaknesses:  
1. Limited 
information gained 
in assessing only 
pre-treatment body 
image.  
2. Study would be 
strengthened by 
assessing the same 
group of patients 
with the same body 
image and 
psychological 
distress measures 
after treatment.  
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Study/Author Purpose Design Variables & 
Instruments 
Relevant Findings Strengths & 
Weaknesses of 
Design 
Assessment of 
problems with 
appearance, 
following surgery 
for oral and oro-
pharyngeal cancer 
using the 
University of 
Washington 
appearance 
domain and the 
Derriford 
appearance scale. 
(Katre et al., 2008) 
To 
describe 
appearanc
e issues in 
patients 
following 
surgery 
for oral 
and oro-
pharyngea
l 
squamous 
cell 
carcinoma
.  
Cross-
sectional.  
252 post-
treatment 
patients 
(55% male, 
45% 
female, no 
racial data 
reported) 
who were 
diagnosed 
and 
treated 
with 
surgery at 
one 
hospital 
between 
1992-2005. 
Patients 
may or 
may not 
have had 
adjuvant 
radiation. 
Study 
conducted 
in Great 
Britain.   
Problems with 
appearance:  
1. DAS24 
 
Quality of life:  
2. UWQOL 
1. 40% (n=98) indicated that 
there was some aspect of their 
appearance that concerned 
them.  
2. Of those, patients were most 
self conscious about their: 
mouth 26% (25/98), face 24% 
(24/98), neck (18/98), and 
teeth 16% (16/98).  
3. The aspect the participants 
did not particularly like about 
their least liked feature was 
disfigurement 37% (37/98), 
scarring 15% (15/98), quality of 
speech 8% (8/98), drooling 7% 
(7/98), and droopy smile 4% 
(4/98).  
4. The Spearman correlation 
between DAS24 score and 
UWQOL appearance score was 
�-0.57 (p<0.001). 
5. Participants with advanced 
tumor stage and participants 
who had received radiation 
had higher appearance 
concerns (p<.01) 
Strengths:  
1. Study examined a 
variety of patients 
who had been 
treated for oral or 
oropharyngeal 
cancer.  
2. DAS24 and 
UWQOL results 
were examined for 
each clinical or 
demographic 
variable.  
Weaknesses:  
1. Study examined 
patients at different 
time points post 
treatment (6 
months-14.5 years 
post treatment) and 
generalized findings.  
2. Within clinical 
groups (oral cancer, 
oropharyngeal 
cancer, surgery only 
, surgery + 
radiation), findings 
were not separated 
by years since 
operation or post 
operative 
complications.  
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Study/Author Purpose Design Variables & 
Instruments 
Relevant Findings Strengths & 
Weaknesses of 
Design 
Facial 
disfigurement in 
patients with 
head and neck 
cancer: the role of 
social self-
efficacy. 
(Hagedoorn & 
Molleman, 2006) 
To 
investigat
e the 
moderatin
g role of 
social self-
efficacy 
with 
respect to 
the link 
between 
facial 
disfigure
ment and 
psychologi
cal and 
social 
functionin
g.  
Cross-
sectional.  
76 Dutch 
head and 
neck 
cancer 
patients 
(58% male, 
42% 
female, no 
racial data 
reported)w
ho were 
between 1-
62 months 
since their 
diagnosis. 
Most had 
undergone 
surgery 
(80%) and 
many 
received 
radiation 
with or 
without 
surgery 
(58%).  
Study 
conducted 
in Holland. 
Facial 
disfigurement – 
patient’s 
perspective:  
2 novel 
questions 
 
Facial 
disfigurement – 
physician’s 
perspective: 7-
point observer 
rated 
disfigurement 
scale (Katz et 
al., 2000) 
 
Social self-
efficacy:  
12 item scale  
(unknown 
origin) 
 
Distress in 
reaction to 
unpleasant 
behavior of 
others:  
4 item scale 
(unknown 
origin) 
 
Social Isolation:  
12 item scale 
(unknown 
origin) 
 
Psychological 
distress: STAI 
 
 
 
 
 
 
 
 
 
 
1. Patients’ perception of facial 
disfigurement was significantly 
associated with time since 
symptoms were first 
experienced (r=.26, p=.03) 
2. the degree of facial 
disfigurement, as judged by 
patients as well as their 
physicians, was positively 
related to psychological 
distress (p=.001) and distress in 
reaction unpleasant behavior 
of others (p=.008), but only 
when patients did not feel self-
efficacious in social encounters 
(p=.009 and p=.041, 
respectively). 
3. social self-efficacy mitigates 
the positive link between facial 
disfigurement as judged by 
patients and social isolation 
(p=.033) 
Strength:  
1. Study 
demonstrated the 
moderating role of 
social self-efficacy in 
the sample 
population of 
patients with head 
and neck cancer  
 
Weaknesses:  
1. Study examined 
patients at different 
time points (1-62 
months post 
diagnosis) and 
generalized findings.  
2. Statistical 
procedures not well 
described.  
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Study/Author Purpose Design Variables & 
Instruments 
Relevant Findings Strengths & 
Weaknesses of 
Design 
Psychosocial 
adjustment in 
head and neck 
cancer: the 
impact of 
disfigurement, 
gender, and social 
support. (Katz et 
al., 2003) 
To 
examine 
the 
psychosoc
ial impact 
of 
disfigure
ment, 
gender, 
and social 
support 
after 
surgical 
treatment 
of head 
and neck 
cancer.  
Cross-
sectional.  
82 patients 
with head 
and neck 
cancer 
(70% male, 
30% 
female, no 
racial data 
reported) 6 
months or 
more after 
treatment 
and free of 
active 
disease.  
Study 
conducted 
in Canada.  
Disfigurement:  
9-point 
observer-rated 
disfigurement 
rating scale 
(Katz et al., 
2000) 
 
Social support:  
Medical 
Outcome Study 
Social Support 
Survey 
 
Social 
desirability: 
Defensive Self-
Enhancement 
subscale of the 
Multidimension
al Self-Esteem 
Inventory 
 
Quality of Life:  
1. CES-D 
2. Bradburn 
Affect Balance 
Scale 
3. Atkinson Life 
Happiness 
Rating 
1. Mean time since surgery: 2.4 
years (range 0.5-14.5 years).  
 
2. Multiple regression analysis:  
A: Depression: significant main 
effects observed for gender 
(beta=0.29, p<.01) and 
disfigurement (beta=0.25, 
p<.01). Increased depressive 
symptoms were reported by 
women and individuals who 
were comparatively more 
disfigured.  
 
B: Psychological well-being: 
significant main effect in well-
being was found for social 
support (beta=0.31, p<.01). 
Individuals who reported 
comparatively higher levels of 
social support also reported 
higher levels of well-being.  
 
C: “Whereas social support 
moderated the relationship 
between disfigurement and 
well-being among women, this 
effect was not evident among 
men.” 
 
“The results of this study 
suggest “women with HNC who 
experience low social support 
and face disfiguring treatment 
are at greatest risk for 
psychological dysfunction” 
Strengths:  
1. Study 
demonstrated the 
moderating role of 
social support 
between 
disfigurement and 
well being among 
women.  
 
2. Detailed 
description of 
multiple regression 
analysis and other 
statistical 
procedures.  
 
Weaknesses:  
1. Study examined 
patients at different 
time points (6 
months-14.5 years 
since surgery) and 
generalized findings.  
 
2. Study did not 
examine differences 
between patients 
who had received 
adjuvant radiation 
therapy and those 
who had not.  
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Descriptive longitudinal design 
Longitudinal data on body image disturbance in this population is limited. Two 
dissimilar studies shown in Table 2 have examined body image and disfigurement 
longitudinally in HNC patients (Millsopp, Brandom, Humphris, Lowe, Stat, & Rogers, 2006 & 
Dropkin, 1999). Assessments were conducted before and after HNC surgery on 
postoperative days 4 through 6 in Dropkin’s (1999) study of hospitalized patients.  Another 
study measured appearance related concerns preoperatively, and at 6, 12, 18, and 24 
months post operatively (Millsopp et al., 2006).  
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Table 2 
Comparison of longitudinal studies 
Study/Author Purpose Design Variables & 
Instruments 
Relevant 
Findings 
Strengths & 
Weaknesses 
of Design 
Facial 
appearance 
after operations 
for oral and 
oropharyngeal 
cancer: a 
comparison of 
casenotes and 
patient-
completed 
questionnaire 
(Millsopp et al., 
2006) 
To review 
the case 
notes of 
patients 
who 
reported 
distress in 
the 
appearanc
e domain 
of the 
University 
of 
Washingt
on Quality 
of Life 
Scale 
(UWQOL) 
and to 
find out 
what help 
they were 
given.  
Longitudinal. 
278 patients 
with oral 
and 
oropharynge
al squamous 
cell 
carcinoma 
(65% male, 
35% female, 
racial data 
not given). 
Assessed 
prior to 
treatment, 
and 6, 12, 
18, and 24 
months post 
treatment. 
Study 
conducted in 
Great 
Britain.  
Appearance related 
concerns:  
Appearance domain 
of the UWQOL 
 1. 41% (n=114) 
identified 
appearance 
related concerns 
at some point 
during 
assessment (38% 
of all men and 
47% of all 
women)  
 
2. In only 7 of 
the 114 was 
there any 
mention of the 
patients’ 
appearance in 
clinic notes, of 
whom 4 were 
given help (2 
scar revision and 
2 oral 
rehabilitations).  
 
3. Factors that 
correlated with 
appearance 
related concerns 
included tumors 
more than 2cm 
in size (p<.001), 
T2 or worse 
stage (p=.001), 
free tissue 
reconstruction 
(p<.001), 
segmental 
mandibular 
resection 
(p=.01), and 
neck dissection 
(p<.001). 
Strength:  
1. Patients 
assessed at 
similar time 
points since 
treatment.  
 
Weaknesses:  
1. Subject 
attrition (@ 
12 months: 
17% had 
died and @ 
24 months: 
26% had 
died).  
 
2. The study 
did not 
examine 
how 
appearance 
related 
concerns 
changed 
over time.  
 
3. No 
specific 
measure for 
body image.    
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Study/Author Purpose Design Variables & 
Instruments 
Relevant 
Findings 
Strengths & 
Weaknesses 
of Design 
Body image and 
quality of life 
after head and 
neck cancer 
surgery. 
(Dropkin, 1999). 
To 
describe 
the 
process of 
body 
image 
reintegrati
on as it 
relates to 
quality of 
life in the 
surgical 
head and 
neck 
cancer 
patient.  
Longitudinal.  
75 patients 
with head 
and neck 
cancer (69% 
male, 31% 
female, 91% 
Caucasian) 
assessed 
before and 
after surgery 
on 
postoperativ
e days 4 
through 6.  
Study 
conducted in 
the United 
States.  
Preoperative coping: 
Ways of Coping 
Questionnaire 
 
Anxiety:  
STAI 
 
Disfigurement:  
Disfigurement/Dysfun
ction Scale (Dropkin, 
1989) 
 
Postoperative coping:  
Coping Behaviors 
Score 
 
Self-care:  
The performance of 
familiar basic hygiene 
such as bathing and 
grooming.  
 
 
1. “Coping 
effectiveness 
was significantly 
lower when 
disfigurative 
surgery was 
anticipated (r = -
.30, p = .004), or 
if the participant 
had undergone 
previous 
radiation or 
chemotherapy (r 
= -.25, p = .008) 
 
2. Although 
there was a 
positive trend 
between anxiety 
and 
disfigurement / 
dysfunction, it 
was not 
statistically 
significant.  
 
3. “Preoperative 
coping ability 
predicted the 
performance of 
postoperative 
coping 
behaviors, or 
self-care and 
resocialization (r 
= .20, p = .03).   
Strengths:  
1. Short 
longitudinal 
design while 
participants 
are 
hospitalized 
led to no 
attrition.  
 
Weaknesses:  
1. There is 
no specific 
measure for 
body image! 
 
2. Assessing 
patients for 
a short 
period of 
time, though 
still a 
longitudinal 
study, does 
not give an 
accurate 
picture of 
how body 
image 
changes 
over a more 
significant 
amount of 
time.  
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Sampling methods  
Convenience sampling, most often from clinic patients, was utilized in all the 
examined descriptive studies. Convenience sampling entails utilizing the most conveniently 
available people that meet study criteria (Polit & Beck, 2008). Although convenience 
sampling is the weakest form of sampling, it is also the most commonly used sampling 
method (Polit & Beck, 2008).  
Face-to-face self-report measure completion method 
Participants completed self-report measures in person in all but one study of body 
image in HNC patients (Katz et al., 2003; Fingeret et al., 2010; Hagedoorn & Molleman, 
2006; Gamba et al., 1992; Dropkin, 1999, Millsopp et al., 2006) The remaining cross-
sectional study utilized the postal system to distribute and obtain the assessment tool 
(Katre et al., 2008). 
Synthesis of study design and methods 
 Design. There are several gaps in the methodological approaches utilized in the 
current literature of body image in patients with cancer related disfigurement. (1) Cross 
sectional studies should compare patients who are at a similar post treatment time point. 
Lumping together patients who have finished treatment 3 months prior with patients who 
have finished treatment 6 years prior and then averaging the body image scores does not 
accurately represent body image for either post-treatment time point. The external validity 
of these studies is limited. (2) There is a lack of longitudinal data on body image in patients 
with HNC. Only two studies have examined body image in this patient population, and they 
both provide limited data (Table 3).   
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Methods. Descriptive mixed methods studies are needed in this population. Similar 
findings from both quantitative and qualitative components would strengthen overall 
conclusions and provide a stronger case for developing interventions that target body 
image in patients with HNC. Given the scarcity of research funding, opportunities to collect 
qualitative and quantitative data within one study should be utilized if at all possible. 
The trajectory for body image disturbance in HNC patients is unknown. Although one study 
(Millsopp et al., 2006) examined appearance related concerns longitudinally, changes 
between assessment points were not reported and a body image specific measure was not 
used. A structured, longitudinal assessment of changes in the body image of patients with 
HNC is needed, and thus is proposed. Existing studies are cross-sectional and do not 
compare patients at similar time points in the post-treatment trajectory. Information gained 
from a longitudinal assessment can be used to better educate clinicians and develop timely 
prevention strategies.  
Synthesis of relevant literature  
The nature of the relationship between body image disturbance and other 
psychosocial variables such as depression, anxiety, and social isolation in patients with HNC 
over the course of treatment and throughout recovery has not been described. Additionally, 
the specific association between degree of disfigurement and body image has not been 
described in patients with HNC or any other cancer with the potential for highly visible 
disfigurement.  The nature of the relationship between functional status deficiency and 
body image disturbance in patients with HNC over the course of treatment and throughout 
recovery is also unclear. It is important that these relationships be explored. A better 
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understanding of the trajectory of body image in patients with HNC and how body image 
and other associated variables are related will enable clinicians to predict how patients may 
react to and cope with disfigurement and dysfunction related to the disease and treatment 
of HNC. This knowledge will enable clinicians to provide better holistic care for patients, 
thus reducing negative social and financial implications for the patient and unnecessary 
resource utilization for the healthcare system as a whole.  
Patients with HNC experience not only highly visible disfigurement, but also physical 
dysfunction. Given the multidimensional components of body image disturbance and the 
course of treatment for this disease, it is particularly important to describe the relationship 
between body image disturbance and functional status deficiencies in patients with HNC. 
This knowledge will be important in understanding the specific contribution of functional 
status deficiency in overall body image disturbance. Describing the impact that functional 
status deficiency has on body image disturbance will support intervention designs that 
holistically address body image in patients with HNC.  
 
Theoretical Framework 
 
There are many frameworks that have been developed to describe body image in 
specific social and medical settings; however, only two have been used to describe the 
components of body image in the HNC population (Dropkin, 1989; Newell, 1999) (Table 3). 
Both are directed at specific aspects of body image research. Neither presents a global 
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conceptual framework to inform us about the causes, important mediators, and moderators 
of body image in HNC.  
The conceptual framework for “coping with disfigurement and dysfunction after 
HNC surgery” was adapted from Lazarus’s stress and coping framework (Dropkin, 1989). It 
was developed, primarily, for nursing research (Dropkin, 1989). It focuses on the immediate 
post-operative period and depicts body image as influenced by preoperative status, level of 
consciousness, need for approval, extent of disfigurement, residual function of the affected 
structure, and an individual’s support system (Dropkin, 1989). The framework depicts 
coping with stress as a gradual movement toward the specified goal of body image 
reintegration (Dropkin, 1989). This framework has been frequently used to describe 
adaptation to disfigurement and dysfunction in this population (Gamba et al., 1992; Monga 
et al., 1997; Dropkin, 2001). 
The fear-avoidance framework of psychosocial difficulties following disfigurement 
has also been used to describe body image (Rumsey et al., 2004; Newell, 2002; Harcourt & 
Rumsey, 2004; Tagkalakis & Demiri, 2009; Konradsen et al., 2009; Arunachalam et al. 2011). 
“Newell’s framework was created to be an alternative cognitive-behavioral approach that 
emphasizes the twin roles of fear and avoidance in maintaining psychosocial difficulties 
following disfigurement” (Newell, 1999). It suggests that fear is likely to lessen with 
continuing exposure and to increase with avoidance, the reactions of others (some people 
inevitably stare at disfigured people) being held constant (Newell, 1999).  
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Table 3 
Components of discussed frameworks 
Framework/Author Discipline / 
Foundation 
 
History of 
Framework 
Major Concepts  Use in studying 
Disfigurement 
and Body 
Image 
Body Image 
Reintegration with 
Head and Neck 
Surgery: Model for 
Coping with 
Postoperative 
Disfigurement/ 
Dysfunction  
(Dropkin, 1989) 
Nursing Adapted from 
Lazarus and 
Folkman’s 
Model of Stress 
and Coping.  
1.Stress 
2.Coping 
3.Self-Care 
4.Resocialization 
5.Confrontation. 
6.Body Image 
Reintegration  
Dropkin, 1999 
Gamba et al, 
1992 
Monga et al., 
1997 
Dropkin, 2001 
Rumsey et al., 
2004 
 
 
Altered Body Image: 
a Fear-Avoidance 
Model of 
Psychosocial 
Difficulties Following 
Disfigurement 
(Newell, 1999).  
 
Nursing Adapted from 
the Fear-
Avoidance 
Model of 
Exaggerated 
Pain Perception 
and the 
Cognitive 
Behavioral 
Formulation of 
Body Image 
Disturbance 
1. Body Image 
2. Psycho-social 
context 
3. Confrontation 
4. Avoidance.  
Newell, 2002 
Rumsey, 2005 
Katre, 2008 
Tagkalakis & 
Demiri, 2009 
Konradsen et 
al., 2009 
Arunachalem 
et al. 2011 
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Because neither of these frameworks adequately explains body image in the specific 
context of HNC, a hypothesized framework (Figure 1) was utilized in this study. The 
framework proposes that HNC therapy results in two main tumor/treatment related 
physical effects: 1) disfigurement and 2) alterations in function (dysfunction). The 
framework depicted in Figure 1 demonstrates that patients may have dysfunction and/or 
disfigurement at any point along the trajectory of their diagnostic and treatment course. 
Personal, social and environmental factors may moderate the effect of dysfunction and 
disfigurement on body image in both a positive and negative direction. For example, 
depression has been shown to interact with disfigurement leading to increased levels of 
body image disturbance. Conversely, social support may mitigate body image disturbance. 
Over time, some patients may accept changes in physical appearance and function leading 
to “reintegration” while others may not. Thus, body image should not be considered static 
but rather an evolving phenomenon.  Understanding body image is important for HNC 
patients in order to maximize self-image, social reintegration, and psychological well-being. 
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Figure 1 
Hypothesized framework for understanding body image in patients with head and neck  
cancer 
 
 
Key Concepts 
 
Body image.  
Body image has been defined in several ways. The dictionary definition calls body 
image the subjective concept of one’s physical appearance based on self-observation and 
the reactions of others (The Free Dictionary, 2012b). Body image has been widely studied in 
relation to eating disorders. In that population, it has been described as having two 
components: (1) “body percept” one aspect of which includes accuracy of body-size 
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estimation and (2) “body concept” which includes body dissatisfaction/disparagement 
(Slade et al., 1990). Body image is also being examined in the context of cancer-related 
disfigurement. Within the population of individuals with cancer-related disfigurement, body 
image is described as a multidimensional concept. Body image has been described in the 
HNC patient population as a highly complex phenomenon that includes an individual’s 
perceptions of his body as a physiological, psychological, and social entity (Dropkin, 1989). It 
has also been described as a complex, multidimensional phenomenon consisting of one’s 
attitudes, perceptions, and experiences pertaining to one’s own physical appearance (Cash 
& Fleming, 2002). Body image is influenced by dissatisfaction with appearance, psychosocial 
distress, and functional decline (Cash & Fleming, 2002). For the purposes of this study, the 
concept of body image was operationalized by the Body Image Quality of Life Inventory 
(BIQLI) (Appendix).  
Cancer related disfigurement.  
Disfigurement has been defined in multiple ways. The most general definition of 
disfigurement is “to mar or spoil the appearance or shape of a person” (The Free Dictionary, 
2012a). Individuals with cancer-related disfigurement have a visibly changed appearance 
and shape related to the disease or its treatment. Because of the laws protecting individuals 
who have been disfigured, disfigurement is also legally defined; to disfigure is to cause 
permanent change in a person’s body, particularly by leaving visible scars that affect a 
person’s appearance (The Free Dictionary, 2012a). Disfigurement has also been defined in 
terms of its impact on the patient; visible disfigurement has been defined as a social 
disability (Rumsey, Clarke, White, Wyn-Williams, & Garlick 2004). Interestingly, there has 
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been no demonstrable relationship between the size or severity of disfigurement and 
psychological distress (Robinson, 1997). This definition makes it seem plausible that an 
individual with a very small hidden area of disfigurement could have significant 
psychological distress while another individual with a larger more obvious disfigurement 
might have minimal psychological distress.  
Facial disfigurement, however, has the most potential for psychological distress. 
“Facial disfigurement is one of the most potentially distressing aspects of HNC because of 
the vital importance of the facial region to self-concept, interpersonal relationships, and 
communication and the fact that facial disfigurement is highly visible” (Koster & Bergsma, 
1990; Moadel, Ostroff, & Schantz, 1998; Katz, Irish, Devins, Rodin, & Gullane, 2000). For the 
purposes of this study, HNC related disfigurement was operationalized by a 9-point 
observer rated scale (Katz et al., 2000) (Appendix).  
Depressive symptoms.  
Depressive symptoms are symptoms associated with depression. Depressed affect, 
lack of positive affect, somatic activity, and interpersonal aspects of depression are four 
categories of depressive symptoms. The presence of these symptoms does not necessarily 
indicate that an individual has clinical depression. The presence of multiple symptoms, 
however, indicates further evaluation of an individual for depression may be warranted. For 
the purposes of this study, depressive symptoms were operationalized by the Center for 
Epidemiologic Studies Depression Scale (CES-D) (Radloff, 1977) (Appendix).  
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Neck-related functional status.  
The ability of an individual move his or her neck and accomplish activities of daily 
living is an indication of neck-related functional status. For the purposes of this study, neck-
related functional status was operationalized by the Neck Disability Index (NDI) (Vernon & 
Mior, 1991)(Appendix) and Cervical Range of Motion (CROM) (Appendix). 
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CHAPTER III 
 
METHODOLOGY 
 
Research Design 
 
 This dissertation study uses and supplements data from a four year, prospective, 
longitudinal, descriptive study that is nearing completion. While the parent study examines 
the development, nature, progression, and prevalence of late-effect fibrosis and/or 
lymphedema as well as biological correlates and psychological stressors in patients with 
HNC, this dissertation study focuses on body image, disfigurement, depressive symptoms, 
and neck-related functional status in patients with HNC. As such, this descriptive 
longitudinal study examines participants before treatment, at the end of treatment, and at 
6, 12, 24, 30, 36, 42, and 48 weeks following the end of treatment.  
 
Description of Research Setting 
 
 Recruitment as well as all study visits took place in private clinic rooms at the 
Vanderbilt Ingram Cancer Center (VICC) in Nashville, TN. The VICC was established in 1993 
and integrates the cancer-related expertise and resources of the School of Medicine, School 
of Nursing, School of Arts and Sciences, School of Engineering, and the Peabody School of 
Education as well as the fully integrated Veterans Administration Medical Center. The VICC 
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earned its initial National Cancer Institute (NCI) designation as a clinical cancer center in 
1995 and joined the elite group of NCI-designated Comprehensive Cancer Centers in 2001.  
 
Sample and Sampling Plan 
 
Inclusion and exclusion criteria 
The targeted population consisted of patients with carcinoma of the head and neck. 
Eligibility criteria included: a) newly diagnosed, histologically proven carcinoma involving 
the head and neck; b) Stage II or greater; c) age of 21 or over; d) willing and able to undergo 
baseline and follow-up assessment at the VICC; and e) the ability to speak English. Patients 
were excluded if: a) they had medical record documentation of cognitive impairment that 
would preclude the ability to provide informed consent; b) were unwilling to undergo 
routine follow-up at the VICC; or c) had recurrent cancer. No restriction was placed on the 
type of treatment; however, treatment parameters were meticulously documented. 
Recruitment 
For the primary study, one hundred subjects were recruited over 25 months from 
newly diagnosed patients with carcinoma of the head and neck undergoing treatment at 
the Vanderbilt Ingram Cancer Center.  Study staff, including the PI, met with individuals who 
were interested in participating in the study and reviewed the informed consent document 
with potential participants. Individuals who wished to participate in the study signed an 
informed consent document. Of the one hundred subjects enrolled in the study, a 
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convenience subsample of 50 participants was followed prospectively for one year in this 
dissertation study by the principal investigator (PI).  
Retention 
The primary study as well as this sub-study was designed to make participation as 
easy as possible. When at all possible, study visits took place on-site on days when 
participants were undergoing routinely scheduled clinic visits. Study visits were scheduled 
to take place during the one hour before or after the clinic visit, and took 45 to 60 minutes. 
To also assist with retention, reminders were sent via email or U.S. Postal mail to each 
participant two weeks prior to their scheduled assessments. These reminders thanked the 
participants for their continued participation, included the date and time of the visit, and a 
list of the assessments that were to be completed. 
Protection of human subjects 
This was a descriptive non-intervention study approved by the Vanderbilt 
Institutional Review Board and the VICC Scientific Review Committee. No investigational 
agents or devices were used. Because psychological distress was being measured for this 
dissertation study, when the scored CESD was 19 or over, VICC procedures were being 
followed: the participant’s attending physician was notified and appropriate referrals were 
made.  Participants’ privacy was also ensured. All patient contact took place in a private 
location at Vanderbilt Medical Center. During visits, family member or other occupants of 
the room were asked to leave the room (unless the participant clearly indicated he/she 
wanted them present). Participants were assigned a study ID number to ensure 
confidentiality. Although, it was necessary for the study team to know participants’ names 
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and numbers during the study to coordinate visits/data collection, the list of names and 
study ID numbers were kept in a password protected computer file on a secure server.  
 
Data Collection Methods 
 
Procedures 
Data collection for this dissertation study is described in Table 4. Data collection was 
completed by trained research personnel, including the PI, and occurred at regularly 
scheduled clinic visits in the Vanderbilt Ingram Cancer Center.  
 
Table 4 
Data Collection Schedule 
1=interview, 2=patient completed, 3=physician or study staff/completed task 
* Disfigurement Scale and BIQLI unique to dissertation study 
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Instruments 
Data collection instruments used for each aim are described below:  
Aim 1. To examine the trajectory of perceived body image in adults with HNC before and 
after treatment and throughout the first year of recovery.  
Body Image Quality of Life Inventory (BIQLI): The BIQLI was developed to quantify the 
effects of one’s own body image on various self-experiences and life contexts (Cash & 
Fleming, 2002). The authors felt that many body image assessment tools typically ignored 
the influence of body image in specific life contexts, and most focused on the evaluative 
dimension as a stable trait rather than as a situationally variable state (Pruzinsky & Cash, 
1990; Thompson, Heinberg, Altabe, & Tantleff-Dunn, 1999). The BIQLI is a 19-item 
instrument whose items reflect domains or contexts in which body image has been found to 
be consequential (Cash & Fleming, 2002). Participants rate the impact of their own body 
image on each of the 19 areas, using a 7-piont bipolar scale from -3 to +3, thereby 
permitting reports of negative, positive, or no impact (Cash & Fleming, 2002). Overall 
impact of body image can be determined by averaging the scores of all items. The BIQLI was 
initially piloted in 116 college women (Cash & Fleming, 2002). To examine convergent 
validity, participants also completed the Multidimensional Body-Self Relations 
Questionnaire (MBSRQ), the Body Areas Satisfaction Scale (BASS), Appearance Schemas 
Inventory (ASI), the Sociocultural Attitudes Toward Appearance Questionnaire (SATAQ), and 
the Objectified Body Consciousness Scale (OBCS) (Cash & Fleming, 2002). A more favorable 
body image quality of life was significantly associated with higher body satisfaction (r = .66, 
p < .001), less body shame (r = -.33, p < .001), less preoccupation with being or becoming fat 
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(r = -.31, p < .002), less dysfunctional investment in appearance (r = -.24, p < .05), and less 
strongly internalized cultural beauty standards (r = -.22, p < .05) (Cash & Fleming, 2002). The 
BIQLI was unrelated to body control beliefs on the OBCS (r = .06) (Cash & Fleming, 2002). 
The internal consistency of the BIQLI was .95 (Cash & Fleming, 2002). No items were found 
to reduce the reliability of the instrument (Cash & Fleming, 2002).  
 A key advantage of the BIQLI is that it measures the influence of body image in 
specific life contexts rather than just assessing body image unidimensionally. Another 
advantage is that it can detect change in the influence of body image on quality of life over 
time, rather than assessing body image as a static trait. Since its initial validation, it has 
been utilized in men and women with the potential for visible disfigurement: oncology 
patients, burn injury patients, and men with HIV (Charles & Dauchy, 2011; Corry, Pruzinsky, 
& Rumsey, 2009; Huang, Lee, Becerra, Santos, Barber, & Matthews, 2006). It’s concurrent 
validity with other unidimensional measures of body image make it an attractive instrument 
to utilize in that the specific impact of body image disturbance can be assessed in addition 
to measuring general body image disturbance. Another advantage of the BIQLI is that it is a 
low cost measure and can be used in research studies inexpensively. Descriptive statistics 
for individual items can be useful in determining where a patient’s body image might be 
problematic.  Individual items as well as the overall score can be used to examine 
associations between other variables of interest.  
 A limitation of the BIQLI is its lack of utilization in the disfigured cancer patient 
population. Although it has been used in over 40 studies since its initial validation, more 
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studies using the BIQLI in the disfigured oncology patient population will strengthen the 
validation of this measure.  
Aim 2. To examine the nature of the relationship between cancer-related disfigurement and 
body image in adults with HNC before and after treatment and throughout the first year of 
recovery.  
Body Image Quality of Life Inventory (BIQLI): see above description 
External Digital Photographs/Disfigurement Scale: External facing and profile digital 
photographs of the head and neck areas were taken the same day as the research visit and 
a 9-point disfigurement scale was applied to each photograph. Disfigurement has been 
quantified in the HNC patient population using a single item 9-point Likert scale to be rated 
by an observer (Katz, Irish, Devins, Rodin, & Gullane, 2000). During development, three 
head and neck surgeons and two nonsurgical research personnel independently rated 74 
nonlaryngectomized HNC patients (Katz et al., 2000). All subjects had been treated 
surgically for HNC at least 6 months earlier and were free of active disease at the time of 
assessment (Katz et al., 2000). Disfigurement is defined for raters on the rating sheet, and 
the rater is then asked to rate the patient’s disfigurement taking into account the size of the 
disfigured area, the degree of face/neck shape distortion, the extent of impairment in facial 
expression, and the visibility of the disfigured area (Katz et al., 2000). These four dimensions 
were chosen based on the clinical experience of the head and neck surgeons involved in the 
study and a review of the literature (Katz et al., 2000). The scale was found to be internally 
consistent (.82). Inter-rater reliability was assessed by examining the relationship between 
independent ratings of disfigurement assigned by surgical and nonsurgical raters (Katz et al., 
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2000). The intraclass correlation coefficient was .91, indicating a very high degree of 
concordance among the raters (Katz et al., 2000). Construct validity was assessed by 
examining the relationship between disfigurement ratings for the surgical and nonsurgical 
raters on the one hand and a number of sociodemographic and illness treatment variables 
on the other (Katz et al., 2000). Greater disfigurement was significantly associated with a 
diagnosis of oral cancer, history of adjuctive radiation, and the type of surgical procedure 
performed (Katz et al., 2000). It was hypothesized that disfigurement ratings would not be 
correlated with sociodemographic factors that would be unlikely to be related to the degree 
of disfigurement; namely age, gender, occupational status, marital status, income level, and 
educational status, supporting the discriminant validity of the scale (Katz et al., 2000). Only 
marital status was found to be significant for the nonsurgeons’ ratings of disfigurement, 
with widowed subjects being rated as more disfigured than married subjects (Katz et al., 
2000). There was no relationship found between the ratings of disfigurement and the age, 
gender, occupational status, income, and education level of the subjects (Katz et al., 2000).  
 A key advantage of the 9-point observer-rated disfigurement scale is that it does not 
lump all patients with a specific surgical procedure into a single rating, a practice that 
ignores individual differences in cosmetic result (Katz et al., 2000).  Additionally, the 
concept of shape is integrated into the scale. Shape is important to consider because it 
encompasses not only the overall cosmetic result but also residual swelling.  
 A limitation of this scale is that limited statistical analyses can be used because of its 
ordinal structure. Although guidelines are provided, there is, for example, no definitive 
difference between a “2” and a “3”. Additionally, it is not clear if the difference between a 
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“2” and a “3” is the same as the difference between a “6” and a “7” in level of increasing 
disfigurement severity. A limitation with any observer rated instrument is that ratings may 
differ among observers.  
Aim 3. To examine the nature of the relationship between body image and depressive 
symptoms in adults with HNC before and after treatment and throughout the first year of 
recovery.  
Body Image Quality of Life Inventory (BIQLI): see above description 
Center for Epidemiological Studies Depression Scale (CESD): The Center for Epidemiologic 
Studies Depression Scale (CES-D) is a 20-item instrument that was designed to measure 
current level of depressive symptomatology, with emphasis on the affective component, 
depressed mood (Radloff, 1977). The symptoms are among those on which a diagnosis of 
clinical depression is based but which may also accompany other diagnoses to some degree 
(Radloff, 1977). Each item is scored 0 “less than one day”, 1 “some or a little of the time (1-2 
days)”, 2 “occasionally or a moderate amount of time (3-4 days)”, or 3 “most or all of the 
time (5-7 days)” (Radloff, 1977). Four items are reverse scored (Radloff, 1977). CES-D items 
were selected from a pool of items from previously validated depression scale (Beck, Ward, 
Mendelson, Mock, & Erbaugh, 1961; Gardner, 1968; Raskin, Schulterbrandt, Reatig, & 
McKeon, 1969; Zung, 1965 in Radloff, 1977). The scale was piloted along with other 
validated scales designed to measure depression or depressed mood, psychological 
symptoms, well-being, and social desirability in household and inpatient psychiatric clinical 
populations (Lubin, 1967; Langner 1962; Cantril, 1965; Crowne & Marlowe, 1960 in Radloff, 
1977). Internal consistency was high for both the general population (.85) and the inpatient 
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psychiatric clinical population (.90) (Radloff, 1977). Both inter-item and item-scale 
correlations were higher in the patient sample than in the general population samples 
(Radloff, 1977). The distribution of scores in the psychiatric patient group was symmetrical, 
with a large standard deviation, while the general population distributions were very 
skewed, with a much larger proportion of low scores (Radloff, 1977). This pattern was 
consistent with the interpretation of the scale as related to a pathological condition more 
typical of a patient population than a household sample (Radloff, 1977). Additionally, the 
CES-D has shown high internal consistency in oncology patients (.89) (Bouma, Ranchor, 
Sanderman, et al., 1995).  
 The CES-D has several strengths. It has been utilized in diverse clinical populations 
with over 13,000 citations in peer-reviewed journals (Web of Knowledge, 2012). It has been 
utilized extensively, in over 300 peer-reviewed articles in the disfigured cancer patient 
population in examining depressive symptoms (Web of Knowledge, 2012). Individual items 
as well as the overall score can be used to examine associations between other variables of 
interest. The CES-D can also be used to alert researchers to participants who might warrant 
further psychological evaluation.  
 A limitation of the CES-D is that it does not diagnose clinical depression (Radloff, 
1977). If diagnosis is not the goal of a particular study, however, this limitation is mitigated. 
Another limitation of the CES-D is that the scores on some items could reflect fatigue not 
related to depression although fatigue can be a symptom of depression (Radloff, 1977).  
Aim 4. To examine the relationship between body image and neck-related functional status 
in adults with HNC before and after treatment and throughout the first year of recovery.  
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Body Image Quality of Life Inventory (BIQLI): see above description 
Neck Disability Index (NDI): This 10-item instrument taps components of daily life that may 
be affected by neck pain and dysfunction. Items include: pain; personal care; lifting; 
reaching; headache; concentration; work; driving; sleeping; and recreation. A Gutman-style 
response format is used, with six possible responses reflecting increasing degrees of 
disability. Items are summed to provide a total score. Items are summed to provide a total 
score (Vernon & Mior, 1991). A score of 10-28% is considered to constitute mild disability, 
30-48% moderate disability, 50-68% severe disability, 72% or more would represent 
complete disability (Vernon & Mior, 1991). Internal consistency of the 10-item scale is 
adequate (α= .89 - .92) (Vernon & Mior, 1991). Factor analysis identified one dimension. 
Stability of the instrument also is adequate (r = .89). Validity of the NDI was supported by 
the moderate to strong correlations with self-reported activity improvement following 
treatment and pain (Vernon & Mior, 1991). 
 A strength of the NDI is that it specifically measures neck-related disability, an 
important issue in patients with HNC. A limitation of the NDI is that scores have the 
potential to be influenced by pain that is not neck specific.  
Cervical Range of Motion (CROM): The Dynatronics CROM-D was used to measure cervical 
range of motion in all planes of movement. The CROM-D measures cervical flexion and 
extension, lateral flexion, and cervical rotation. The CROM-D is aligned on the nose-bridge 
and ears and is fastened to the head by a Velcro strap (University of Minnesota, 1988). 
Three dial angle meters are used to take the measurements (University of Minnesota, 
1988). The sagittal plane meter and the lateral flexion meter are gravity meters (University 
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of Minnesota, 1988). The rotation meter is magnetic and responds quickly to the shoulder-
mounted magnetic yoke, accurately measuring cervical rotation (University of Minnesota, 
1988). Because the magnetic yoke controls the rotation meter, shoulder substitution is 
eliminated (University of Minnesota, 1988). It has demonstrated clinical validity and 
reliability (ICC=.89-.98) when compared with other measures of cervical range of motion 
(r=.93-98) (Audette, Dumas, Cote, De Serres, 2010).  
 A key strength of using the CROM-D is that it is relatively easy to use and does not 
require the patient to move from a sitting position. It uses standardized landmarks and 
positioning, improving reproducibility of measurements, and it can be quickly read. 
Additionally, it has been used to measure cervical range of in patients with HNC in several 
studies (Ahlberg, Nikolaidis, Engstrom, Gunnarsson, Johansson, Sharp, & Laurell, 2012; van 
Wilgen, Dijkstra, van der Laan, Plukker, & Roodenburg, 2004; Lennox, Shafer, Hatcher, Beil, 
& Funder, 2002).  
 A limitation of using the CROM-D is that the magnetic yolk cannot be used with 
patients who have a pacemaker, decreasing the accuracy of readings.  
Other data collection instruments 
Data were collected on demographic variables (age, race/ethnicity, marital status, 
employment, insurance, education) through self-report. Clinical variables (date of cancer 
diagnosis, treatment received/planned, radiation dose, radiation schedule, stage, and 
medications taken) were obtained from participant medical records. Tobacco and alcohol 
use were assessed through self-report. 
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Data Analysis 
 
Overview 
Longitudinal assessment of body image was conducted at ten points in time and 
spaced sufficiently close together in order to detect critical “turning” or “inflection” points 
in the trajectory. Group-based trajectory modeling methods are model ‘fitting’, not model 
‘testing’, approaches (Nagin & Land, 1993; Nagin, 1999; Nagin, 2005). That is, they are 
descriptive, data-reducing, exploratory, detection tools (Nagin & Land, 1993; Nagin, 1999; 
Nagin, 2005). Longitudinal clustering approaches are designed to detect patterns in complex 
longitudinal data and help to illuminate the key characteristics of the groups (or clusters) of 
cases displaying particular patterns (Nagin & Land, 1993; Nagin, 1999; Nagin, 2005). “This 
analysis is similar to exploratory factor and cluster analysis but rather than identifying 
clusters of correlated values in a cross-sectional set of scores, the clustered values are in 
longitudinal scores from repeat assessments of the same cases.” (Anderson, Kaufman, 
Dietrich, et al., 2012). This exploratory approach was used to analyze the trajectory of body 
image in this study. Disfigurement, depressive symptoms, and neck-related functional 
status were also assessed at each of the ten study time points. In order to better 
understand the relationship between each of these variables and body image, cross-lagged 
panel correlations between each of these variables and body image was performed. SAS 
version 9.2 and SPSS Version 19 were used to conduct all statistical analyses. All statistical 
significance tests maintained maximum type I error rates (alpha values) of no more than 
.05. 
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Data cleaning 
 Data cleaning was performed on all data before analysis. Data sets were first visually 
inspected. Any obvious errors were corrected using hard copies of the data. Data sets were 
then analyzed in SAS for any differences.  Identified differences were each inspected and 
verified by hard copies of the data.  
Management of missing data 
Randomly missing responses to items within the self-report assessment tools (e.g., 
BIQLI, CESD, NDI) were handled via protocols specified by the instrument developers. When 
there was no specified protocol, if the participant has completed 75% or more of the items 
on a particular instrument, the mean score for that instrument was calculated using 
available item responses and used in subsequent analyses.  
Descriptive statistics 
Descriptive statistics were used to summarize and initially inspect the distributions 
of demographic and study measures. To ensure that parametric statistical methods were 
used appropriately, the shapes of the distributions of the continuous measures were 
evaluated to determine the extent of any potential violations of parametric statistical 
assumptions (i.e., normality). If parametric assumptions were required and not met, 
nonparametric modeling procedures were used. The preference was to keep the 
distributions in the form that most closely reflected the clinical population represented in 
this study and that provided the most clinically meaningful conclusions. 
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Analysis of specific aims 
The following data analysis methods were used to examine each aim:  
1. To examine the trajectory of perceived body image in adults with HNC before and after 
treatment and throughout the first year of recovery.  
Instrument: Body Image Quality of Life Inventory (BIQLI) 
Method of analysis: A group based trajectory modeling approach was used to detect 
subgroups of participants with similar longitudinal patterns of body image.   Identified 
subgroups were examined for differences in baseline demographic characteristics, disease 
and treatment characteristics, levels of disfigurement, depressive symptoms, and neck-
related function.  
2. To examine the nature of the relationship between cancer-related disfigurement and 
body image in adults with HNC before and after treatment and throughout the first year of 
recovery.  
Instruments: Body Image Quality of Life Inventory (BIQLI) and the Disfigurement Scale  
Method of analysis: Spearman correlations were used to determine the association 
between body image and disfigurement at each assessment point.  
3. To examine the nature of the relationship between body image and depressive symptoms 
in adults with HNC before and after treatment and throughout the first year of recovery.  
Instruments: Body Image Quality of Life Inventory (BIQLI) and the Center for 
Epidemiological Studies Depression Scale (CESD) 
Method of analysis: Simultaneous and cross-lagged (single lagged assessment) correlations 
of transformed data were conducted between depressive symptoms and body image.  
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4. To examine the relationship between body image and neck-related functional status in 
adults with HNC before and after treatment and throughout the first year of recovery.  
Instruments: Body Image Quality of Life Inventory (BIQLI), Neck Disability Index (NDI), and 
the Cervical Range of Motion (CROM) 
Method of analysis: Simultaneous and cross-lagged (single lagged assessment) correlations 
of transformed data were conducted between neck-related functional status and body 
image.  
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CHAPTER IV 
 
RESULTS 
 
This chapter consists of seven sections. Sample characteristics are presented in 
section one. Sections two through five present descriptive data on body image, 
disfigurement, depressive symptoms, and neck-related functional status. Analysis and 
results of each research question are presented in section six. A summary of the findings is 
presented in section seven.  
 
Sample 
 
The demographic characteristics of study participants are summarized in Table 5.  
Participants (N=50) ranged from age 31 to 78 years (m = 57.3 years, SD = 10.2 years). The 
majority of participants were male (n=37, 74%), Caucasian (n=45, 90%), and married (n=40, 
80%).  Most participants had at least a high school education (n=44, 88%), and 42% (n=21) 
were employed full time at the beginning of the study. The majority of participants had a 
history of tobacco use (n=28, 56%) and alcohol use (n=29, 58%). Over one third of 
participants had an annual household of less than $30,000 (n=18, 36%).  
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Table 5   
Demographic characteristics.  
 
Characteristic Frequency (%), N=50 
Sex   
    Male  37 (74) 
    Female  13 (26) 
Race   
    White  45 (90) 
    Black  2 (4) 
    Asian  2 (4) 
    American Indian  1 (2) 
Education level   
    < 12
th
 grade  6 (12) 
    ≥ 12
th
 grade  44 (88) 
Marital status   
    Single/widowed/other  10 (20) 
    Married/live w/partner  40 (80)  
Employment status   
    Employed full time  21 (42) 
    Employed part time  3 (6) 
    Retired  13 (26) 
    Unemployed  11 (22) 
    Other  2 (4) 
Insurance status   
    Medicare  10 (20) 
    Medicaid  3 (6) 
    Private insurance  26 (52) 
    None  8 (16) 
    Other  3 (6) 
Household Income   
    10,000 or less  5 (10 
    10,001-20,000  7 (14) 
    20,001-30,000  6 (12) 
    30,001-40,000  8 (16) 
    40,001-50,000  3 (6) 
    50,001-60,000  4 (8) 
    Over 60,000  10 (20) 
    Do not care to respond  7 (14) 
Smoking (any current or past use)   
    Yes  28 (56) 
    No  22 (44) 
Alcohol (any current or past use)   
    Yes  29 (58) 
    No  21 (42) 
Age, mean, median  57.3, 57.5 
    IQR 25-75  50.8-65.0 
    min, max  31, 78 
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The disease and treatment characteristics for the sample are shown in Table 6. The 
most frequent tumor location for participants was the oropharynx (n=23, 46%). The 
majority of participants had tumor stage of Stage III or above (n=48, 96%).  Most 
participants had a squamous cell carcinoma type of tumor (n=39, 78%). Thirty-eight percent 
of participants (n=19) had an HPV-related tumor. All participants had undergone some type 
of radiation treatment, and the majority had concurrent chemotherapy (n=49, 98%). Forty-
four percent of participants (n=22) had surgery as part of their treatment, and the most 
common surgical procedure was a radical neck dissection (n=12, 24%). Almost half of the 
participants had a PEG tube (n=24, 48%).  
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Table 6 
Head and neck cancer disease and treatment characteristics 
 
Characteristic Frequency (%), N=50 
Tumor location   
    Nasal cavity  1 (2) 
    Paranasal sinuses  2 (4) 
    Oral cavity  9 (18) 
    Nasopharynx  4 (8) 
    Oropharynx  23 (46) 
    Larynx  5 (10) 
    Salivary gland  5 (10) 
    Other  1 (2) 
Tumor TNM Stage   
    Stage I  1 (2) 
    Stage II  1 (2) 
    Stage III  9 (18) 
    Stage IVa  34 (68) 
    Stage IVb  5 (10) 
Type of tumor   
 Squamous Cell Carcinoma  39 (78) 
 Nasopharyn. Carcinoma  3 (6) 
 Salivary Duct Carcinoma  2 (4) 
 Acinic Cell Carcinoma  1 (2) 
 Spindle Cell Carcinoma  1 (2) 
 Olfactory Neuroblastoma  1 (2) 
 Adenoic Cystic Carcinoma  2 (4) 
 Other  1 (2) 
HPV-related tumor   
    Yes  19 (38) 
    No  31 (62) 
Surgery   
    Yes  22 (44) 
    No  28 (56) 
Chemotherapy   
    Yes  49 (98) 
    No  1 (2) 
CCR   
    Yes  49 (98) 
    No  1 (2) 
Type of surgery    
    RND  12 (24) 
    Modified ND  2 (4) 
    Total Laryngectomy  2 (4) 
    Partial Laryngectomy  1 (2) 
    Tonsillectomy     2(4) 
    Parotidectomy  1(2) 
    Orbital exenteration  1(2) 
    Septoplasty,sinusotomy   1(2) 
Trach   
    Yes  9 (18) 
    No  41 (82) 
PEG   
    Yes  24 (48) 
    No  26 (52) 
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Sixteen participants (32%) withdrew from the study. Six participants (12%) withdrew 
due to recurrent cancer. Four participants (8%) transferred their care to another health care 
facility. Two participants (4%) chose not to continue participation in the study. One 
participant (2%) was withdrawn due to substance abuse, and one participant (2%) was non-
compliant with study procedures. One participant (2%) was withdrawn after a mental status 
change, and one participant (2%) died during the course of the study. The participants who 
withdrew from the study did so at varying study time points. Four participants (8%) 
withdrew prior to the end of treatment visit. Three participants (6%) withdrew prior to the 
12W visit. One participant (2%) withdrew prior to the 18W visit. Two participants (4%) 
withdrew prior to the 24W visit. Two participants (4%) withdrew prior to the 30W visit. One 
participant (2%) withdrew prior to the 36W visit. Three participants (6%) withdrew prior to 
the 42W visit. The only statistically significant difference between not withdrawn and 
withdrawn participants was type of residence. Participants who withdrew from the study 
were more likely to live in an urban setting (n=11 of 16, 69% vs. 8 of 34, 24%, p = 0.008). 
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Reliability 
 
 Each of the self-report measures had acceptable internal consistency at each study 
time point (See Table 7).  
 
Table 7 
Cronbach’s alpha of self-report measures 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
BIQLI .97 .96 .98 .97 .97 .97 .96 .98 .98 .98 
CESD .86 .82 .78 .86 .86 .83 .84 .77 .87 .81 
NDI .82 .76 .78 .76 .85 .86 .88 .84 .87 .90 
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Body Image 
 
Body image was measured using the BIQLI that ascertains the impact of body image 
on quality of life using a bipolar scale of -3 to +3. Positive composite scores indicate a 
positive effect of body image on quality of life and negative composite scores indicate a 
negative effect of body image on quality of life. Median body image remained positive 
throughout the study (Table 8). Negative composite scores, however, were seen at every 
assessment point with the exception of forty-two weeks post treatment. Median body 
image scores for participants included in the trajectory analysis were similar to median body 
image scores for the sample.  
 
 
Table 8 
Body image  
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 44 43 40 34 37 26 31 22 23 
Median 
(Inc.Trajectory) 
.4 
(.6) 
.4 
(.2) 
.3 
(.1) 
.9 
(1.0) 
1.0 
(.9) 
.9 
(1.1) 
1.0 
(.8) 
1.1 
(1.2) 
1.1 
(1.1) 
1.6 
(1.6) 
IQR 
(Inc.Trajectory) 
-.1, 1.6 
(-.1, 1.7) 
-.2, 1.1 
(-.3 ,1.5) 
-.2, 1.4 
(-.4, 1.7) 
0, 1.7 
(.3, 1.8) 
0, 1.8 
(0, 1.7) 
0, 2.0 
(-.1, 2.1) 
0, 1.5 
(0, 1.4) 
.3, 2.4 
(.5, 2.4) 
0, 2.0 
(0, 2.0) 
0, 2.7 
(0, 2.7) 
Min, Max -2.0,3.0 -2.0, 3.0 -2.3, 2.8 -1.2, 3.0 -1.6, 3.0 -1.1, 3.0 -1.7, 2.8 -.8, 2.6 .9, 2.6 -1.8, 3.0 
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Disfigurement 
 
Disfigurement was measured using a 9-point observer-rated disfigurement scale 
with a 0 indicating no disfigurement and a 9 indicating severe disfigurement. Examples of a 
“1”, “5”, and “9” are provided as part of the scale (see Appendix). Prior to assigning a 
disfigurement score to participant photos, intra-rater reliability was established. Five photo 
sets (front, left profile, right profile) were rated using the observer-rated disfigurement 
scale at two different rating sessions, one week apart. Intra-rater reliability was found to be 
acceptable (.90). After establishing initial intra-rater reliability, the remaining photo sets 
were scored.  
In order to establish inter-rater reliability, 10% (n=36) of photos were randomly 
selected for the dissertation chair to score. The PI trained the dissertation chair on this 
method of photo rating in two phases. The dissertation chair was given the observer-rated 
disfigurement scale, and an initial batch of 36 photo sets was rated. Following this, each 
photo set was analyzed by both the PI and the dissertation chair in order to establish 
consistent rating of photos. A second batch of 36 photo sets was given to the dissertation 
chair for rating. After the training procedure, inter-rater reliability was found to be 
acceptable (.95).  
Median levels of disfigurement using the 9-point scale were relatively low 
throughout the study (Table 9). However, scores were positively skewed, and the full range 
of scores was seen at each assessment point. Median disfigurement was the highest 
immediately following the end of treatment. Median disfigurement scores for participants 
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included in the trajectory analysis of body image were similar to median disfigurement 
scores for the sample. 
 
Table 9 
Disfigurement  
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 45 45 39 36 37 28 32 22 23 
Median 
(Inc.Trajectory) 
0 
(0) 
2 
(2) 
1 
(1) 
1 
(1) 
1 
(1) 
1 
(1) 
0 
(1) 
1 
(1) 
1 
(1) 
1 
(1) 
IQR 
(Inc.Trajectory) 
0, 2 
(0, 2) 
0, 3 
(1, 3) 
0, 2 
(0,2) 
0, 3 
(0, 2) 
0, 2 
(0, 2) 
0, 1 
(0, 2) 
0, 2 
(0, 2) 
0, 1 
(0, 1) 
0, 2 
(0, 2) 
0, 1 
(0, 1) 
Min, Max 0, 9 0, 9 0, 9 0, 9 0, 9 0, 9 0, 9 0, 9 0, 9 0, 9 
 
 
Depressive Symptoms 
 
Depressive symptoms were measured using the CESD. Participants who scored a 19 
or greater were referred to their medical oncologist for further evaluation. Median levels of 
depressive symptoms were highest immediately following the end of treatment (Table 10). 
At baseline, depressive symptoms, as measured by the CESD, were similar in those who did 
and did not withdraw from the study. Median levels of depressive symptoms returned to 
those similar to baseline at eighteen weeks following the end of treatment. The median 
CESD score was lowest at 48 weeks following the end of treatment. Median depressive 
symptom scores for participants included in the trajectory analysis of body image were 
similar to median depressive symptom scores for the sample. 
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Table 10 
Depressive symptoms  
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 44 44 40 35 37 28 32 22 23 
Median 
(Inc. 
Trajectory) 
12 
(12) 
17 
(17) 
16 
(12) 
13 
(14) 
12 
(12) 
8 
(9) 
7 
(7) 
10 
(0) 
9 
(9) 
5 
(4) 
IQR 
(Inc. 
Trajectory) 
8, 20 
(9, 19) 
11, 25 
(11, 25) 
5, 25 
(6, 28) 
6, 22 
(4, 23) 
3, 16 
(3,22) 
3, 19 
(2,20) 
4, 12 
(5,21) 
2, 17 
(0,17) 
3, 19 
(3,19) 
0, 16 
(0,16) 
Min, Max 0, 47 2, 42 0, 52 0, 44 0, 44 0, 43 0, 44 0, 39 0, 45 0, 40 
 
 
Neck-Related Functional Status 
 
Neck-related functional status was assessed using two instruments, the NDI and the 
CROM. The NDI measured neck-related disability, and the CROM measured cervical range of 
motion. The NDI categorizes level of disability by percentage. For example, a 0-20% on the 
NDI is categorized as “minimal”. Individuals with “minimal” disability can cope with most 
living activities (Pollard, 1984). A 21-40% on the NDI is categorized as “moderate”. 
Individuals with “moderate” disability experience more pain and difficulty with sitting, 
lifting, and standing. Travel and social life are more difficult, and these patients may be 
disabled from work (Pollard, 1984). Neck-related function as measured by the NDI was 
lowest (higher level of disability) immediately following the end of treatment (median level 
of neck-related disability = 25%). Neck-related function increased throughout the study and 
were the highest at forty-eight weeks post treatment (median level of neck-related 
disability = 6%) (Table 11). Median NDI scores for participants included in the trajectory 
analysis of body image were similar to median NDI scores for the sample. 
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 CROM results are shown in Tables 12-17. Range of motion measurements for the 
CROM are 0-45 for forward flexion, 0-45 for extension, 0-45 for left lateral flexion, 0-45 for 
right lateral flexion, 0-80 for left lateral rotation, and 0-80 for right lateral rotation. Median 
cervical flexion, left lateral movement, right lateral movement, left rotation, and right 
rotation were all below the normal range of motion at baseline, indicating that many 
participants had reduced range of motion before receiving radiation and chemotherapy 
treatment for their disease.  Median cervical extension was normal throughout the study. 
Median left and right cervical lateral movement was limited at every time point. Median left 
and right cervical rotation was also limited at every time point. However, it is important to 
note that participants at every time point had reduced cervical range of motion.  No 
consistent patterns of increase or decrease in range of motion occurred throughout the 
study. Median CROM scores for participants included in the trajectory analysis of body 
image were similar to median CROM scores for the sample. 
 
   
Table 11 
Neck-related function (Neck Disability Index)  
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 44 44 40 35 37 28 32 22 23 
Median 
(Inc.Trajectory) 
18% 
(12%) 
25% 
(22%) 
19% 
(16%) 
16% 
(18%) 
12% 
(8%) 
8% 
(6%) 
9% 
(10%) 
7% 
(6%) 
7% 
(7%) 
6% 
(6%) 
IQR 
(Inc.Trajectory) 
4, 32 
(4, 32) 
14, 32 
(14, 31) 
11,30 
(8, 24) 
8, 26 
(8, 31) 
6, 24 
(2,23) 
2, 25 
(0,26) 
2, 24 
(1,25) 
0, 22 
(0,20) 
2, 26 
(2,26) 
0, 26 
(0,26) 
Min, Max 0, 59 0, 76 0, 70 0, 42 0, 70 0, 38 0, 40 0, 44 0, 48 0, 40 
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Table 12 
Neck-related function (Cervical Range of Motion) – flexion 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 44 39 35 37 28 32 22 23 
Median 
(Inc.Trajectory) 
44 
(49) 
50 
(51) 
48 
(49) 
49 
(49) 
45 
(45) 
46 
(48) 
46 
(47) 
45 
(46) 
49 
(49) 
45 
(45) 
IQR 
(Inc.Trajectory) 
35,50 
(35,50) 
41,55 
(46,57) 
39,54 
(43,54) 
39,51 
(40,53) 
41, 50 
(41,50) 
39,51 
(41,52) 
39,51 
(39,52) 
40,51 
(40,52) 
40,55 
(40,55) 
39,51 
(39,51) 
Min, Max 19, 76 23, 68 20,70 21,71 26, 67 20,68 31,72 27,68 26,69 31,69 
 
 
 
Table 13 
Neck-related function (Cervical Range of Motion) - extension 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 41 44 39 35 37 28 32 22 23 
Median 
(Inc.Trajectory) 
51 
(52) 
52 
(54) 
56 
(54) 
56 
(57) 
50 
(50) 
50 
(50) 
51 
(51) 
52 
(52) 
52 
(52) 
47 
(47) 
IQR 
(Inc.Trajectory) 
41,65 
(43,67) 
40,67 
(40,67) 
40,67 
(40,67) 
42,63 
(40,64) 
35, 61 
(37,64) 
42,60 
(40,59) 
42,60 
(41,60) 
41,61 
(41,63) 
44,62 
(44,61) 
39,63 
(39,63) 
Min, Max 19, 89 20, 80 20, 82 21, 83 10,83 11,81 27,73 18,75 19,80 18,79 
 
 
 
Table 14 
Neck-related function (Cervical Range of Motion) – left lateral 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 44 39 35 37 28 32 22 23 
Median 
(Inc.Trajectory) 
33 
(33) 
38 
(38) 
37 
(36) 
33 
(32) 
35 
(35) 
32 
(32) 
34 
(34) 
38 
(38) 
33 
(33) 
33 
(33) 
IQR 
(Inc.Trajectory) 
29,43 
(29,42) 
30,46 
(31,49) 
31,47 
(32,43) 
29,41 
(29,42) 
32,41 
(33,44) 
29,41 
(27,40) 
28,45 
(26,43) 
31,42 
(30,43) 
30,40 
(30,40) 
26,40 
(26,40) 
Min, Max 13, 54 18, 75 19, 58 21, 64 13,59 18,69 13,67 18,60 19,51 10,51 
 
 
 
Table 15 
Neck-related function (Cervical Range of Motion) – right lateral 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 44 39 35 37 28 32 22 23 
Median 
(Inc.Trajectory) 
32 
(31) 
33 
(33) 
34 
(32) 
32 
(31) 
28 
(28) 
30 
(28) 
31 
(29) 
29 
(29) 
29 
(29) 
28 
(28) 
IQR 
(Inc.Trajectory) 
25,40 
(25,40) 
29,44 
(29,42) 
30,42 
(28,41) 
29,39 
(26,36) 
21,39 
(21,38) 
22,38 
(22,33) 
24,39 
(23,36) 
22,38 
(21,37) 
24,37 
(24,37) 
20,33 
(20,33) 
Min, Max 9, 55 10, 57 10, 55 17, 60 4, 53 13,68 13,61 17,51 18,44 13,46 
60 
 
 
 
Table 16 
Neck-related function (Cervical Range of Motion) – left rotation 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 44 39 35 37 28 32 22 23 
Median 
(Inc.Trajectory) 
54 
(53) 
57 
(60) 
56 
(53) 
59 
(57) 
56 
(56) 
60 
(59) 
61 
(60) 
50 
(55) 
57 
(57) 
57 
(57) 
IQR 
(Inc.Trajectory) 
45,60 
(43,59) 
51,67 
(51,67) 
50,66 
(50,64) 
48,69 
(48,67) 
46,61 
(46,61) 
49,65 
(47,64) 
51,68 
(51,68) 
44,65 
(45,68) 
46,65 
(46,65) 
47,63 
(47,63) 
Min, Max 22, 71 21, 85 22, 92 31, 80 29, 79 26,81 34,80 23,81 40,76 26,73 
 
 
 
Table 17 
Neck-related function (Cervical Range of Motion) – right rotation 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 44 39 35 37 28 32 22 23 
Median 
(Inc.Trajectory) 
54 
(54) 
54 
(53) 
59 
(59) 
54 
(54) 
60 
(60) 
57 
(54) 
59 
(61) 
52 
(52) 
58 
(58) 
54 
(54) 
IQR 
(Inc.Trajectory) 
48,63 
(49,64) 
48,62 
(46,61) 
50,67 
(52,64) 
47,67 
(47,61) 
45, 64 
(49,64) 
49,66 
(49,67) 
49,67 
(49,68) 
49,62 
(49,61) 
46,63 
(46,63) 
45,61 
(45,61) 
Min, Max 12,77 20, 77 21,100 21,77 18, 79 31,77 39,71 29,75 30,71 33,73 
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Data Analysis 
 
Research Question 1. What is the trajectory of perceived body image in adults with HNC 
before and after treatment and throughout the first year of recovery?  
 To answer this question, a Nagin group based trajectory modeling approach in SAS 
was used to detect subgroups of participants with similar longitudinal patterns of body 
image. In order to be included, participants had to have, at a minimum, baseline data, 24 or 
30 week post treatment data, and 42 or 48 week post treatment data. Twenty-seven 
participants met the criteria for inclusion in this analysis.  
In order to identify statistically significant changes in body image over the course of 
the study, a generalized estimating equation was used to test the generalized linear model. 
Body image was found to be statistically significant for the overall model (χ2= 31.92, df = 9, p 
< .001). Post hoc tests using the Bonferroni correction method revealed that only the 
increase in body image from 6 weeks post treatment to 12 weeks post treatment was 
statistically significant (χ2= 8.076, df = 1, p = .040).  
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Figure 2 
Body image participants included in trajectory analysis 
 
Three distinct clusters of trajectories were identified. Body image scores of 
individuals in each of the three trajectory clusters are shown in Tables 18-20 and 
graphically, in Figures 3-5. Although not statistically significant, participants in cluster 1 had 
poorer median body image scores throughout the study than clusters 2 and 3. (Tables 18-
20). Participants in cluster 2 had a positive median body image score at baseline but this 
dropped to a negative median body image score at the end of treatment (Table 19). Median 
body image scores in this cluster became slightly more positive as the study progressed 
(Table 19). Participants in cluster 3 had a slightly positive median body image score at 
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baseline which improved as the study progressed to a very positive median body image 
score at 48 weeks post treatment (Table 20).   
 
 
Table 18 
Body image scores for cluster 1  
Group 1 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
N  5 5 5 5 5 5 4 3 4 4 
Median -.79 -.74 -1.32 -.95 -.95 -.79 -.68 -.55 -.48 -.61 
Minimum -1.53 -1.16 -2.26 -1.21 -1.58 -1.11 -1.68 -.82 -.86 -1.79 
Maximum .58 1.11 .11 .26 .26 -.26 .32 -.23 -.23 -.11 
 
 
 
Figure 3 
Body image trajectory for cluster 1 
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Table 19 
Body image scores for cluster 2 
Group 2 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
N  12 12 11 11 10 11 7 11 11 10 
Median 1.29 -.16 .05 .95 .89 .58 .84 1.05 .55 1.58 
Minimum .00 -2.00 -1.74 -1.16 .00 -.21 .00 .00 .00 .00 
Maximum 2.00 3.00 1.32 2.00 1.95 2.00 1.42 2.59 2.41 2.53 
 
 
 
Figure 4 
Body image trajectory for cluster 2 
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Table 20 
Body image scores for cluster 3 
Group 3 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
N  10 9 9 10 9 10 8 10 7 9 
Median .42 1.63 2.21 2.05 1.74 2.66 1.34 2.34 2.18 2.79 
Minimum -.68 -.47 -.47 .26 .00 1.47 .00 .95 1.77 .00 
Maximum 3.00 2.58 2.79 3.00 2.95 3.00 2.84 2.59 2.59 3.00 
 
 
 
 
 
Figure 5 
Body image trajectory for cluster 3 
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These clusters were examined for differences in baseline demographic 
characteristics, disease characteristics, baseline levels of disfigurement, baseline depressive 
symptoms, and baseline neck-related function. Nominal data were examined using the chi-
square test and continuous data were examined using the Kruskal-Wallis test. No 
statistically significant differences were shown among the three clusters in terms of 
baseline demographic characteristics, disease characteristics, and the other study measures 
(disfigurement, depressive symptoms, and neck-related functional status).  
Although no statistically significant differences in the clusters were noted at 
baseline, some notable patterns were identified. Individuals in Cluster 1 had higher median 
levels of depressive symptoms (median = 19) as measured by the CESD than individuals in 
Clusters 2 or 3 (medians = 9.5, 9.5, respectively). Lower levels of neck-related function as 
measured by increased scores on the NDI were noted in Cluster 1 (median =28%) than 
Clusters 2 or 3 (medians = 5%, 17%, respectively). Additionally, the proportion of individuals 
taking antidepressant medication was higher in Cluster 1 (n=3, 60%) than Clusters 2 (n=4, 
33%) or 3 (n=2, 20%).  Individuals in Cluster 2 reported current or past medical concerns 
(n=11, 92%) at a higher percentage than individuals in Cluster 1 (n=4, 80%) or Cluster 3 (n=5, 
50%).   
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Research Question 2. What is the nature of the relationship between cancer-related 
disfigurement and body image in adults with HNC before and after treatment and 
throughout the first year of recovery? 
 To answer this question, bivariate correlations between the composite BIQLI score 
and the disfigurement score were obtained for each study assessment point. Body image 
was not statistically significantly associated with disfigurement at any study assessment 
point (see Table 21).     
 
 
Table 21 
Association between body image and disfigurement 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 44 43 39 34 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
-.13 
(.02) 
-.03 
(.02) 
.03 
(-.12) 
.03 
(.08) 
.04 
(.04) 
-.05 
(-.06) 
.01 
(.11) 
.08 
(.23) 
.39 
(.39) 
.26 
(.26) 
p 
(Inc.Trajectory) 
0.376 
(0.922) 
0.859 
(0.937) 
0.859 
(0.584) 
0.863 
(0.700) 
0.836 
(0.861) 
0.765 
(0.767) 
0.981 
(0.648) 
0.679 
(0.291) 
0.075 
(0.075) 
0.233 
(0.233) 
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Research Question 3. What is the nature of the relationship between body image and 
depressive symptoms in adults with HNC before and after treatment and throughout the 
first year of recovery? 
 To answer this question, bivariate correlations between the composite BIQLI score 
and the CESD score were obtained for each study assessment point. Body image and 
depressive symptoms were inversely associated in this sample (see Table 22). Higher levels 
of depressive symptoms were associated with poorer body image. The strongest 
correlations were noted at twelve weeks and thirty six weeks following the end of 
treatment (r=-.55, p<.001; r=-.54, p=.002).  
 
Table 22 
Association between body image and depressive symptoms 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 44 43 40 34 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
-.21 
(-.10) 
-.32 * 
(-.37) 
-.50* 
(-.54*) 
-.55* 
(-.62*) 
-.30 
(-.26) 
-.42* 
(-.46*) 
-.38* 
(-.39) 
-.54* 
(-.50*) 
-.46* 
(-.46*) 
-.33 
(-.33) 
p 
(Inc.Trajectory) 
0.153 
(0.605) 
0.032 
(0.066) 
0.001 
(0.006) 
<0.001 
(<0.001) 
0.083 
(0.217) 
0.010 
(0.018) 
0.053 
(0.103) 
0.002 
(0.013) 
0.033 
(0.033) 
0.121 
(0.121) 
 
 
In order to further investigate the relationship between body image and depressive 
symptoms, a single-lag cross-lagged panel analysis was conducted. Because of the limited 
sample size, only a single-lagged panel analysis could be conducted (Figure 6). Although no 
clear consistent patterns of lagged influence were found, with the exception of between the 
first two times of assessment, each measure shows good test-retest reliability. Poor test-
retest reliability between baseline and the end of treatment might be attributed to post-
treatment cognitive impairment of some participant at the end of treatment.  
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Figure 6 
Cross-lagged panel analysis of body image and depressive symptoms 
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Research Question 4. What is the nature of the relationship between body image and neck-
related functional status in adults with HNC before and after treatment and throughout the 
first year of recovery? 
 To answer this question, bivariate correlations of the NDI and the CROM scores with 
the composite BIQLI score were generated at each study assessment point. Correlations 
between body image and neck-related functional status were generally small and not 
statistically significant. While possibly a spurious finding given the large number of 
correlations generated, at thirty six weeks after the end of treatment, participants with a 
greater level of neck-related disability had poorer body image than those with lower levels 
of neck-related disability (r=-.41, p=.002) (Table 23). No consistent associations were shown 
between the composite BIQLI score and CROM (Tables 24-29).  
 
Table 23 
Association between body image and neck-related function (Neck Disability Index) 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 44 43 40 34 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
-.13 
(-.23) 
-.08 
(-.27) 
.03 
(-.01) 
-.22 
(-.47*) 
-.14 
(-.20) 
-.20 
(-.23) 
-.18 
(-.28) 
-.41* 
(-.41*) 
-.27 
(-.27) 
-.29 
(-.29) 
p 
(Inc.Trajectory) 
0.356 
(0.249) 
0.612 
(0.185) 
0.837 
(0.949) 
0.184 
(0.014) 
0.442 
(0.353) 
0.234 
(0.235) 
0.390 
(0.242) 
0.022 
(0.047) 
0.220 
(0.220) 
0.174 
(0.174) 
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Table 24 
Association between body image and neck-related function (Cervical Range of Motion) - flexion 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 43 39 33 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
.32* 
(.41*) 
-.02 
(.01) 
.19 
(.27) 
.39* 
(.61*) 
.18 
(.39) 
.17 
(.17) 
.27 
(.30) 
.06 
(-.01) 
-.34 
(-.34) 
.25 
(.25) 
p 
(Inc.Trajectory) 
0.026 
(0.036) 
0.879 
(0.954) 
0.225 
(0.193) 
0.014 
(0.001) 
0.305 
(0.056) 
0.320 
(0.411) 
0.184 
(0.212) 
0.735 
(0.964) 
0.123 
(0.123) 
0.251 
(0.251) 
 
 
 
 
 
Table 25 
Association between body image and neck-related function (Cervical Range of Motion) - extension 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 41 43 39 33 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
.10 
(.20) 
-.02 
(.21) 
.00 
(.20) 
.03 
(.00) 
.03 
(.12) 
.27 
(.29) 
-.12 
(-.12) 
.23 
(.39) 
-.53* 
(-.53*) 
.00 
(.00) 
p 
(Inc.Trajectory) 
0.497 
(0.320) 
0.920 
(0.308) 
0.992 
(0.334) 
0.871 
(0.999) 
0.851 
(0.563) 
0.101 
(0.151) 
0.559 
(0.612) 
0.211 
(0.057) 
0.012 
(0.012) 
0.998 
(0.998) 
 
 
 
 
 
Table 26 
Association between body image and neck-related function (Cervical Range of Motion) – left lateral 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 43 39 33 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
.05 
(.31) 
-.04 
(-.01) 
.12 
(.05) 
.05 
(.09) 
.16 
(.20) 
.32* 
(.29) 
-.02 
(.10) 
.41* 
(.45*) 
-.39 
(-.39) 
-.15 
(-.15) 
p 
(Inc.Trajectory) 
0.711 
(0.114) 
0.780 
(0.975) 
0.448 
(0.799) 
0.785 
(0.660) 
0.381 
(0.340) 
0.052 
(0.155) 
0.917 
(0.688) 
0.023 
(0.029) 
0.072 
(0.072) 
0.509 
(0.509) 
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Table 27 
Association between body image and neck-related function (Cervical Range of Motion) – right lateral 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 43 39 33 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
-.04 
(.14) 
.23 
(.46*) 
-.00 
(-.11) 
.11 
(.29) 
.34* 
(.45*) 
.32* 
(.29) 
.17 
(.26) 
0.48* 
(.59*) 
-.32 
(-.32) 
-.03 
(-.03) 
p 
(Inc.Trajectory) 
0.794 
(0.479) 
0.143 
(0.017) 
0.992 
(0.606) 
0.505 
(0.155) 
0.052 
(0.026) 
0.055 
(0.145) 
0.417 
(0.286) 
0.006 
(0.002) 
0.148 
(0.148) 
0.881 
(0.881) 
 
 
 
 
 
Table 28 
Association between body image and neck-related function (Cervical Range of Motion) – left rotation 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 43 39 33 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
-.12 
(-.07) 
-.02 
(.16) 
.07 
(.11) 
.37* 
(.53*) 
.19 
(.22) 
.07 
(.06) 
-.14 
(.01) 
.10 
(.15) 
-.42 
(-.42) 
-.17 
(-.17) 
p 
(Inc.Trajectory) 
0.411 
(0.723) 
0.886 
(0.433) 
0.675 
(0.601) 
0.020 
(0.007) 
0.296 
(0.294) 
0.695 
(0.755) 
0.503 
(0.983) 
0.595 
(0.497) 
0.050 
(0.050) 
0.451 
(0.451) 
 
 
 
 
 
Table 29 
Association between body image and neck-related function (Cervical Range of Motion) – right rotation 
 BL EOT 6W 12W 18W 24W 30W 36W 42W 48W 
n 50 42 43 39 33 37 26 31 22 23 
Spearman’s rho 
(Inc.Trajectory) 
.03 
(.04) 
.30* 
(.38) 
.08 
(.09) 
.12 
(.13) 
.05 
(-.03) 
.14 
(.10) 
.02 
(-.05) 
-.01 
(.11) 
-.30 
(-.30) 
-.09 
(-.09) 
p 
(Inc.Trajectory) 
0.850 
(0.850) 
0.052 
(0.055) 
0.620 
(0.674) 
0.460 
(0.546) 
0.786 
(0.879) 
0.422 
(0.613) 
0.919 
(0.835) 
0.958 
(0.615) 
0.184 
(0.183) 
0.676 
(0.767) 
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In order to further investigate the relationship between body image and neck-
related disability, a single-lag a cross-lagged panel analysis was conducted. Because of the 
limited sample size, only a single-lagged panel analysis could be conducted (Figure 7). 
Although no clear consistent patterns of lagged influence, again with the exception of the 
first two times of assessment, each measure demonstrated good test-retest reliability. Poor 
test-retest reliability between baseline and the end of treatment might be attributed to 
post-treatment cognitive impairment of some participants at the end of treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 
Cross-lagged panel analysis of body image and neck-related function (Neck Disability Index) 
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Summary 
 
This chapter presented results from statistical analyses of body image, disfigurement, 
depressive symptoms, and neck-related function as well as demographic and clinical data. A 
summary and discussion of these results as well as study strengths and limitations are 
presented in Chapter V.  
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CHAPTER V 
 
DISCUSSION 
 
Sample Characteristics 
 
Demographic characteristics in this study were similar to that of other studies 
reported in the literature as well as that of the population. Participants (N=50) in this study 
had an average age of 57.3 years, similar to the 57.7 years in Fingeret et al.’s (2010) study, 
59.9 years in Fingeret et al.’s (2012) study, and 58 years in Hagedoorn and Molleman’s 
(2006) study. This is consistent with the national average of 50 -70 years (American Cancer 
Society, 2012).  The majority of participants in this study were male (n=37, 74%), similar to 
63.9% in Fingeret et al.’s (2012) study, 56% in Fingeret et al.’s (2010) study, 55% in Katre’s 
(2008) study, 58% in Hagedoorn and Molleman’s (2006) study, and 69.5% in Katz et al.’s 
(2003) study. This is consistent with the national 3:1, male to female, ratio of HNC diagnosis 
(American Cancer Society, 2012).  Most participants in this study were married or partnered 
(n=40, 80%), similar to 78.9% in Fingeret et al.’s (2012) study, 68% in Fingeret et al.’s (2010) 
study, and 68.3% in Katz et al.’s (2003) study. Many participants in this study were from 
lower income families. Over one third of participants had an annual household income of 
less than $30,000 (n=18, 36%). At 130% of the federal poverty level, a family of four with an 
income of $30,000 would qualify for food stamps (US Census Bureau, 2013). Most 
participants in this study had at least a high school education (n=44, 88%), similar to 93% in 
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Fingeret et al.’s (2012) study, 69.3% in Fingeret et al.’s (2010) study, and 85.4% in Katz et 
al.’s (2008) study. The majority of participants in this study had a history of tobacco use 
(n=28, 56%), similar to 69.3% in Fingeret et al.’s (2010) study. This is slightly less than the 
national estimate of 75% tobacco use in individuals diagnosed with HNC (American Cancer 
Society, 2012). In addition, most participants in this study were Caucasian (n=45, 90%) 
similar to 88% in Fingeret et al.’s (2012) study and similar to national racial demographics of 
81% (National Cancer Institute, 2012). The demographics of the sample used for this study, 
suggest that participants are representative of patients with HNC with respect to the 
characteristics mentioned above.  
 
 
Study Measures 
 
Body image  
The median positive body image increased throughout the study and was highest at 
the end of the study (baseline median = .4, 48W median = 1.6). This study is one of the few 
that have assessed body image longitudinally in this population. Roberge et al.’s (2000) 
study found that body image improved at four weeks post feeding tube placement as 
compared with week one post feeding tube placement. Millsopp et al.’s (2006) study found 
that 41% of participants identified appearance related concerns at some point in the 18 
months post-surgery, but a longitudinal analysis was not performed. In this study, median 
body image was the lowest at six weeks post treatment. This nadir in body image occurs 
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during the time that many acute side effects of treatment are still problematic. Mucositis, 
dysphagia, increased salivary viscosity, taste alterations, and limitations in jaw movement 
can remain problematic for many patients in the three months following the end of HNC 
treatment (Epstein, Thariat, Bensadoun, Barasch, Murphy, Kolnick, Popplewell, & Maghami, 
2012). It is evident that the effects of HNC and its treatment do not end immediately after 
treatment is completed. It could be hypothesized that as a patient with HNC finishes 
treatment and begins to recover more normal functions of daily life, body image becomes 
more important as the patient is reestablishing his or her role in the family and greater 
society. Although the BIQLI scale allowed participants to rank their body image experience 
as negative or positive in relation to important activities, a scale better targeted to patients 
with HNC might have yielded more meaningful information.  
 
Disfigurement. 
Median levels of disfigurement were relatively low throughout the study. However, 
the full range of scores was seen at each assessment point. Median disfigurement was the 
highest immediately following the end of treatment (median score = 2). No other studies of 
patients with HNC have assessed disfigurement longitudinally. Two studies, however, by 
Katz et al.,(2000, 2003) revealed low levels of disfigurement (3.7, 3.6) in participants with 
head and neck cancer more than six months from the end of treatment. Although the 9-
point observer-rated scale takes into account the size and visibility of facial disfigurement, 
some patients may have changes in their appearance that cannot be accounted for with this 
method. Patients recovering from HNC often have external appliances such as a nasogastric 
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tube or a tracheostomy. No standard way of accounting for these appliances made it 
difficult to accurately rate the level of disfigurement experienced by these participants. It 
can be argued that a better way to measure disfigurement in this population would be to 
compare facial appearance before and after treatment. Because all the participants in this 
study received radiation therapy as part of their HNC treatment, changes in appearance 
may have not been well captured by the 9-point disfigurement scale that was developed for 
use with post-surgical patients. For example, changes in skin texture and color, often caused 
by radiation treatment are not addressed by the 9-point disfigurement scale. Additionally, 
facial weight gain or loss, changes in facial symmetry, as well as localized swelling all have 
the ability to greatly change how a person looks, but they are also not well categorized 
using the 9-point observer rated scale. This scale may have greatly underestimated levels of 
true disfigurement and thus the change in appearance experienced by participants. 
Depressive symptoms.  
Median levels of depressive symptoms were highest immediately following the end 
of treatment, similar to Hammerlid et al.’s (1998) study and Sehlen et al.’s (2003) that 
examined depression immediately following the end of treatment. In this study, median 
depressive symptoms returned to baseline levels at 18W post treatment. Depressive 
symptoms continued to decrease throughout the remaining study assessments. This is 
similar to Johansson et al.’s (2011) study where participants reported decreased anxiety and 
levels of depression eleven months following the end of treatment. It is evident that 
patients with HNC have increased depressive symptoms in close proximity to their diagnosis 
and treatment. As time from the end of treatment progresses, however, these symptoms 
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decrease. Median levels of depressive symptoms, in this study, were the lowest at 48 weeks 
post-treatment (median = 5). This is lower than baseline median depressive symptoms 
(median = 12). It is thought that as patients with HNC are treated for their disease and who 
recover without recurrence in the year following treatment, depressive symptoms lessen.  
Neck-related function 
Neck-related function as measured by the NDI was lowest immediately following the 
end of treatment with a median of 25%, indicating moderate disability. No other known 
studies have measured neck-related function with the NDI in adults with head and neck 
cancer at comparable time points. This coincides with the acute treatment-related side 
effects, such as changes in skin texture and irritation at the radiation port experienced by 
many patients in the three months following the end of treatment. Neck-related function 
increased throughout the study and was the highest at forty-eight weeks post treatment 
with a median of 6%. Although not statistically significant, neck-related function as 
measured by the NDI was poorer for participants who withdrew from the study than for 
those who remained in the study. At 6 weeks post treatment, the median NDI score for all 
individuals enrolled in the study was 19%, indicating minimal disability, as opposed to 29%, 
indicating moderate disability, for those patients that eventually withdrew from the study. 
Although not statistically significant, it is evident that participants who eventually withdrew 
from the study had poorer neck-related function as measured by the NDI than participants 
who remained in the study. At forty-eight weeks post treatment, median neck-related 
function as measured by the NDI was better than that at baseline. This increase in neck-
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related function is consistent with decreasing treatment-related side effects as the length of 
time from the end of treatment increases.  
Baseline median CROM scores were below the normal range of motion for flexion, 
left lateral movement, right lateral movement, left rotation, and right rotation. This 
indicates that prior to chemotherapy and radiation treatment, participants had limitations 
in their cervical range of motion. It is unclear what specifically this limitation is attributed to, 
but a variety of causal factors such as tumor burden, inflammation, lymphedema, surgical 
procedures, and advancing age may all contribute to this deficiency.   Additionally, median 
left and right lateral cervical movement, and left and right cervical rotation were below the 
normal range of motion at every study time point.  Median cervical extension was normal at 
every study time point. The range of cervical extension scores, however, included 
individuals with limitations in their range of motion at every time point. Although, CROM 
measurements for participants did not show any consistent patterns of increase or decrease 
over study time points, it is evident that limitations in cervical range of motion remained for 
many participants throughout the year following the end of treatment.  
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Research Questions 
 
Question 1. What is the trajectory of perceived body image in adults with HNC before and 
after treatment and throughout the first year of recovery?  
 No other studies have examined the trajectory of body image in patients with HNC. 
Three clusters of body image trajectories were identified in this study. Participants in 
Cluster 1 had negative body image at baseline, maintained negative body image scores 
throughout study assessments, and had a negative median body image score at 48 weeks 
post treatment. Cluster 1 had the highest rates of antidepressant use, highest median 
depressive symptoms at baseline, and poorest neck-related function at baseline. 
Participants in Cluster 2 had a moderately positive median body image at baseline, which 
dipped to a negative median body image score at the end of treatment, and then slowly 
increased to a moderately positive median body image score at 48 weeks post treatment. 
Cluster 2 had the highest proportion of members with current or past medical concerns 
among the three clusters. Participants in Cluster 3 had a slightly positive median body image 
at baseline but then increased to a highly positive median body image at 48 weeks post 
treatment. Although sample sizes were not large enough to detect statistical differences 
among the clusters in terms of demographic characteristics, disease characteristics, and 
scores on other baseline measures, descriptive statistics suggest that individuals with higher 
levels of depressive symptoms and poorer neck-related function may also have poorer body 
image. It is also possible that among patients with positive body image, the influence of 
83 
other co-morbid conditions may be an important factor in the longitudinal body image of a 
patient with HNC.  
For the sample as a whole, participants who had positive body image to begin with 
generally ended the study with better body image than other participants. Although 
positive body image declined shortly after the end of treatment, the majority of participants 
ended the study with similar levels of positive body image. A statistically significant increase 
in body image was found between six weeks post treatment and twelve weeks post 
treatment. No other studies have examined the trajectory of body image in patients with 
HNC. Because it appears that body image at baseline is similar to body image at 48 weeks 
post treatment, it is important to identify patients who have poor body image prior to 
treatment. Patients with higher numbers of co-morbidities may particularly be in need of 
additional resources that address not only body image, but also depressive symptoms and 
neck-related function. Identification of these patients and early intervention may lead to 
better overall outcomes in terms of body image as well as a lessened side-effect burden 
during treatment and recovery from HNC.  
Research Question 2. What is the nature of the relationship between cancer-related 
disfigurement and body image in adults with HNC before and after treatment and 
throughout the first year of recovery? 
 No relationship was found between body image and cancer-related disfigurement in 
this study. Although body image and disfigurement have not been previously assessed in 
this population, this result is similar to Katz et al.’s (2000) study and Katz et al.’s (2003) 
study where disfigurement was not found to be associated with measures of adjustment. 
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Although Dropkin’s (1999) study examined disfigurement in this population, disfigurement 
was measured by surgical procedure, and was subsequently used as a proxy for body image. 
The 9-point observer-rated scale, although developed for use with post-surgical HNC 
patients, has somewhat limited utility in assessing the disfigurement experienced by 
patients who have received radiation therapy. A study assessing disfigurement in terms of 
comparing appearance before and after treatment might yield different results. This study 
supports a holistic definition of body image that is not strictly based on appearance. This 
study supported the hypothesized theoretical framework by showing that body image was a 
separate concept from disfigurement. Body image encompasses how a person feels about 
his or her appearance.  It is evident that other factors play a role in determining a person’s 
body image.  This finding also supports the argument that body image and appearance are 
not the same. For this reason, level of disfigurement cannot be used as a proxy measure for 
body image.  
Research Question 3. What is the nature of the relationship between body image and 
depressive symptoms in adults with HNC before and after treatment and throughout the 
first year of recovery? 
 An increase in depressive symptoms was consistently associated with poorer body 
image in this study (Table 19). This is similar to Fingeret et al.’s (2010) study where poorer 
body image was associated with psychological distress (BSI-18) and Fingeret et al.’s (2012) 
study where poorer body image was associated decreased well-being. Although cross-
lagged panel analysis did not predict depression influencing future body image, it is clear 
that the two constructs are associated. This study supported the hypothesized theoretical 
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framework by showing that body image and depressive symptoms are related.  It is unclear 
at this time whether poorer body image influences depressive symptoms or whether an 
increased number of depressive symptoms contribute to poorer body image. It is also 
unclear if depressive symptoms are an outcome of poorer body image or if poorer body 
image is an outcome of an increase in depressive symptoms. It is clear, however, at 
baseline, that different trajectories of body image do not differ based on depressive 
symptoms in a statistically significant manner. Further inquiry may provide a better 
understanding of the relationship between body image and depressive symptoms.  
Research Question 4. What is the nature of the relationship between body image and neck-
related functional status in adults with HNC before and after treatment and throughout the 
first year of recovery? 
 No other studies have examined the relationship between body image and neck-
related function in patients with head and neck cancer.  Although body image has been 
associated with other functional measures in some studies, no relationship between body 
image and neck-related function was shown in this study. Fingeret et al.’s (2012) study 
showed that individuals with speech and/or eating concerns had increased body image 
dissatisfaction as compared with other individuals. Fingeret et al.’s (2012) study also 
showed that increased body image dissatisfaction was associated with a general decrease in 
general physical function. Similar patterns of symptoms, however, were seen between body 
image and neck-related functional status in this study. Body image was poorest following 
treatment and gradually improved. The same pattern was seen in neck-related function as 
measured by the NDI.  This makes sense, however, given that patients with HNC do not 
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begin to feel better and gain relief from the acute side effects of treatment that affect neck-
related function until almost three months after the end of treatment.  Although body 
image and neck-related function may not be directly associated, there is the possibility that 
other measures of function more specifically tied to body image related issues are 
associated. Because body image is how a person feels about the way he or she looks, it is 
logical that individuals with speech and/or eating concerns would have poorer body image. 
Additionally, it will be important to assess if body image is associated with other functional 
domains more specifically linked to appearance like sexuality and employment.  
 
Strengths and Limitations 
 
Strengths 
 This dissertation study is unique in that it is the first known study to examine the 
trajectory of body image in patients with HNC. The instruments utilized in this study showed 
excellent internal consistency and test-retest reliability. No other known study has 
examined body image longitudinally in this population. The sample examined in this 
dissertation study was very similar to that of other published studies and the population. 
The statistically significant increase in body image from six to twelve weeks after the end of 
treatment observed in this study coincides with the lessening of acute side effects from 
treatment. A key strength of this study is the different trajectories for body image in adults 
with head and neck cancer that have been identified. This is also the first study to assess the 
relationships between body image and related variables repeatedly in the year following 
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the end of treatment.  No other studies have examined the relationship between body 
image and neck-related function. Another strength of this study is the framework for 
understanding body image in patients with HNC.  This model supported the association 
between body image and depressive symptoms observed in the study.  
Limitations 
 A key limitation of this study is the small sample size. A larger sample size would 
maximize the likelihood of finding statistically significant associations between the studied 
variables as well as statistically significant differences among the three trajectories of body 
image. Because of the small sample size, this study did not control for age, gender, or HPV 
status in examining body image in this population, which might have yielded valuable 
information in a large sample.  Another limitation of this study was the high attrition rate 
(n=16, 32%). Participants who did not complete the study had higher levels of depressive 
symptoms and neck-related disability, which is plausible since the majority of participants 
who withdrew had recurrent disease. Had these participants remained in the study, analysis 
of their body image trajectories could have yielded valuable information related to 
supportive care needs. Thus there may clinically significant areas of patient concerns that 
could be amenable to nursing interventions that were not identified in this study due to 
sample size limitations. Although the sample was demographically similar to that of other 
studies, the changing demographics of patients with HNC make it important to include 
younger patients and females in research studies, particularly those assessing supportive 
care issues. Another limitation of this study is that many participants received lymphedema 
therapy, physical therapy, and corrective posture instruction. If this study had been 
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conducted in a setting without access to these interventions, neck-related function, as 
measured by the Neck Disability Index as well cervical range of motion, might have been 
much poorer. Demographic and disease and treatment variables were not controlled for 
when examining the CROM measurements. Individuals who had a neck dissection or who 
were elderly would be expected to have considerably less cervical range of motion than 
individuals who were younger or who had not had surgery. Another limitation is that the 
theoretical framework was not supported in terms of neck-related function being 
associated with body image. This valuable information, however, can be used to explore 
other, perhaps more relevant areas of function.  
 
Implications for Nursing  
 
Early assessment of body image in patients diagnosed with HNC is an important part 
of holistic nursing care.  The new findings from this study further support early assessment 
of body image in patients with HNC. Because patients with poorer baseline body image 
appear to also have higher levels of depressive symptoms, increased use of antidepressants, 
and poorer neck-related function, it is important that these patients be identified early and 
monitored for changes throughout treatment and during recovery. Additionally, the 
association between poorer body image and depressive symptoms is key in understanding 
the symptom clusters that patients with HNC experience. Identifying poor body image and 
the presence of depressive symptoms early increases the likelihood of effective 
intervention. The identification of widespread limitations in cervical range of motion 
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throughout the treatment and recovery continuum represent another opportunity for 
nursing intervention.  
 
Recommendations for Future Research 
 
Because of the high attrition rate, future studies in the population may need to be 
conducted at multiple sites in order obtain adequate sample sizes. Future studies that 
control for variables such as age, gender, and HPV status are needed to thoroughly examine 
body image in the context of HNC. It is also important that future studies target minority 
patients. Assessment of patients’ baseline body image prior to treatment may facilitate 
early identification of individuals with baseline poor body image. Pilot studies of 
interventions that target such individuals, particularly at the end of treatment and in the 
three months following the end of treatment, are indicated in order to determine if they 
would be helpful to this subset of patients.   Additionally, tumor specific measures of 
disfigurement for patients with HNC would yield more useful information when ascertaining 
the impact of disfigurement.  Further exploration of the context of disfigurement in patients 
with HNC will lead to more holistic patient care. Further testing of the hypothesized 
conceptual framework is needed to more accurately understand the interactions between 
body image and associated concepts in this population. Because of the association between 
depressive symptoms and poor body image, targeted interventions have the potential to 
increase overall wellbeing of patients with HNC. Additionally, more research needs to be 
done to identify which areas of function are associated with body image. Although neck-
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related function does not appear to be associated with body image, other areas more 
specifically related to how a person feels about their appearance such as sexuality and 
employment may be of interest.  
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Patient Demographic and Clinical Information Form  
 
Patient Interview; 
1. What is your birthdate?     ____/____/_______ (month/day/year) 
 
2. Gender:  
(1) Female___(2) Male____ 
(3) Other____(4) Do not care to respond___ 
 
3. What is your race? 
(1) American Indian/Alaskan Native____   
(2) Asian____   
(3) Native Hawaiian or Other Pacific Islander 
      _____ 
(4) Black or African American_____ 
(5) White_____ 
Nation of Origin: _______________ 
 
4. What is the highest grade of education you completed? (Please circle) 
 1      2     3     4     5     6    7    8    9   10   11 12 (high school) 13  14    15   16  (college)      
17  18  (master)  19  20  (doctorate) 
 
5. What is your marital status?  
(1) Single____    
(2) Single, living with partner_____          
(3) Married_____ 
(4) Widowed____    
(5) Other____ 
 
6. What is your current employment status? 
(1) Employed full time____      
(2) Employed part time____     
(3) Homemaker____  
(4) Retired_____                         
(5) Unemployed_____                  
(6) Other____ 
Vocation_____________________________ 
 
7. What best describes your area of residence? 
(1) City___ (2) Country ___ (3) Other___ 
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Chart Review 
 
 
8. Health Maintenance 
8.1 Smoking/Dipping/Chewing 
(1) No  ____ 
(2) Yes ___(Tobacco__or Marijuana__or ___) 
   _____years _____ cigarettes per day  
   _____ dips per day ____ plugs/chaw per day 
(3) Quit _____When____________ 
(4) Not Quit ______  
_____cigarettes per day (Current) 
 
 
8.2 Drinking Alcohol 
(1) No ____ 
(2) Yes ____ 
_____years _____ times per week 
(3) Quit ______When__________ 
(4) Not Quit ______ 
_____ times per week (Current) 
 
9. What is your insurance coverage? 
(1) Medicare____ (2) Medicaid____  
(3) TennCare____ (4) Private Insurance____ 
(5) HMO____         (6) None_____                      
(7) Other_____ 
 
10. Do you have any medical problems?  
(1) No 
(2) Yes (e.g., HBP, DM, Obesity, Injury History) _____________________________________ 
 
11. What is your yearly household income? 
(1) $10,000 or less____      
(2) $10,001 to $ 20,000____    
(3) $20,001 to $ 30,000____ 
(4) $30,001-$40,000___     
(5) $ 40,001 to $50,000____    
(6) $50,001 to $60,000 ____ 
(7) Over $60,000____         
(8) Do not care to respond____ 
 
 
 
 
Head and Neck Cancer Disease and Treatment Information Form 
 
Diagnosis 
Date ____/____/_____(mm/dd/year) 
 
 
Type  
(Location/Originating cancerous lesions) 
___(1) Nasal cavity   
___(2) Paranasal sinuses 
___(3) Oral cavity 
___(4) Nasopharynx 
___(5) Oropharynx 
___(6) Hypopharynx  
___(7) Larynx 
___(8) Salivary gland 
___(9) Other______________  
 
Stage: T____N____M____ 
___X 
___0  
___I 
___IIa 
___IIb 
___IIIa 
___IIIb 
___IVa 
___IVb 
___IVc 
 
 
Surgery 
Date____/___/_____ 
Type: 
___(1) Standard RND (radical neck dissection) 
___(2) Bilateral RND 
___(3) Modified RND 
___(4) Modified neck dissection 
___(5) Functional neck dissection 
___(6) Selective neck dissection 
___(7) Other________________  
Number of dissected lymph nodes____ 
Number of positive lymph nodes____ 
 
 
 
 
Radiation Therapy 
___None 
___Some 
Site (1) ____________ Dosage______cGy 
Site (2) ____________ Dosage______cGy 
Site (3) ____________ Dosage______cGy 
Site (4) ____________ Dosage______cGy 
Begin date____/____/_____ 
End date  ____/____/_____ 
Pattern of therapy  
 
Days on to days off ratios_______ 
Chemotherapy 
Induction __ Yes___No 
___None 
___some 
Number of cycles____ 
Begin date____/____/_____ 
End date  ____/____/_____ 
Type:  
____(1) Taxol 
____(2) Carboplatin 
(3) Other:_________________________  
 
ChemoXRT 
___None 
___Some 
Begin date____/____/_____ 
End date  ____/____/_____ 
Type:  
____(1) Taxol 
____(2) Carboplatin 
(3) Other:_________________________  
 
Total treatment received 
___ (1) Induction+ ChemoXRT 
___ (2) ChemoXRT 
___ (3) Surgery + ChemoXRT 
___ (4) Surgery + Radiotherapy 
___ (5) Surgery only 
___ (6) Radiotherapy only 
___ (7) other (please list)_________ 
Treatment-related complications_______ 
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The BIQLI Questionnaire 
 
Instructions: Different people have different feelings about their physical appearance. 
These feelings are called “body image.”  Some people are generally satisfied with their 
looks, while others are dissatisfied. At the same time, people differ in terms of how their 
body-image experiences affect other aspects of their lives. Body image may have 
positive effects, negative effects, or no effect at all. Listed below are various ways that 
your own body image may or may not influence your life.  For each item, circle how and 
how much your feelings about your appearance affect that aspect of your life.  Before 
answering each item, think carefully about the answer that most accurately reflects how 
your body image usually affects you. 
 
-3                 -2                 -1                 0                 +1                 +2                 +3 
 
 
Very 
 
Moderate 
 
Slight 
 
No 
 
Slight 
 
Moderate 
 
Very 
Negative Negative Negative Effect Positive Positive Positive 
Effect Effect Effect  Effect Effect Effect 
 
1. My basic feelings about myself— 
feelings of personal adequacy and self-worth. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
2. 
 
My feelings about my adequacy as a 
man or woman—feelings of masculinity 
or femininity. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
3. 
 
My interactions with people of my own sex. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
4. 
 
My interactions with people of the other sex. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
5. 
 
My experiences when I meet new people. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
6. 
 
My experiences at work or at school. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
7. 
 
My relationships with friends. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
8. 
 
My relationships with family members. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
9. 
 
My day-to-day emotions. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
10. 
 
My satisfaction with my life in general. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
 
 
99 
11. My feelings of acceptability 
as a sexual partner. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
12. 
 
My enjoyment of my sex life. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
13. 
 
My ability to control what and how much 
I eat. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
14. 
 
My ability to control my weight. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
15. 
 
My activities for physical exercise. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
16. 
 
My willingness to do things that might 
call attention to my appearance. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
17. 
 
My daily “grooming” activities 
(i.e., getting dressed and physically ready 
for the day). 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
18. 
 
How confident I feel in my everyday life. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
19. 
 
How happy I feel in my everyday life. 
 
-3 
 
-2 
 
-1 
 
0 
 
+1 
 
+2 
 
+3 
 
( TF Cash, 2002) 
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CESD 
 
Below is a list of ways you might have felt or behaved. Please tell me how often you have 
felt this way during the past week. 
  
 Hardly 
ever or 
none of 
the time 
(less than 
1 day) 
Some or a 
little of the 
time (1-2 
days) 
Occasionally 
or a moderate 
amount of the 
time (3-4 
days) 
Most or all 
of the time 
(5-7days) 
1. I was bothered by things that usually 
don’t bother me. 
 
0 1 2 3 
2. I did not feel like eating; my appetite 
was poor. 
 
0 1 2 3 
3. I felt that I could not shake off the 
blues even with help from my family 
or friends. 
0 1 2 3 
4. I felt I was just as good as other 
people. 
 
0 1 2 3 
5. I had trouble keeping my mind on 
what I was doing. 
 
0 1 2 3 
6. I felt depressed.  
 
 
0 1 2 3 
7. I felt that everything I did was an 
effort.  
 
0 1 2 3 
8. I felt hopeful about the future. 
 
 
0 1 2 3 
9. I thought my life had been a failure. 
 
 
0 1 2 3 
10. I felt fearful. 
 
 
0 1 2 3 
11. My sleep was restless.  
 
 
0 1 2 3 
12. I was happy.  
 
0 1 2 3 
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13. I talked less than usual. 
 
 
0 1 2 3 
14. I felt lonely.  
 
 
0 1 2 3 
15. People were unfriendly.  
 
 
0 1 2 3 
16. I enjoyed life.  
 
 
0 1 2 3 
17. I had crying spells. 
 
0 1 2 3 
18. I felt sad.  
 
 
0 1 2 3 
19. I felt that people disliked me.  
 
 
0 1 2 3 
20. I could not get "going".  
 
 
0 1 2 3 
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Cervical Range of Motion (CROM)    
VISIT _____________ 
 
The subject’s CROM parameters: 
(1) Forward flexion________degrees  (normal: 0-45 degrees) 
(2) Extension ____________ degrees  (normal: 0-45 degrees) 
(3) Left lateral flexion_____  degrees  (normal: 0-45 degrees) 
(4) Right lateral flexion____  degrees  (normal: 0-45 degrees) 
(5) Left lateral rotation_____degrees  (normal: 0-80 degrees) 
(6) Right lateral rotation____degrees (normal: 0-80 degrees) 
______________________________________________________________ 
 
 (1) Forward flexion________degrees  (normal: 0-45 degrees) 
(2) Extension ____________ degrees  (normal: 0-45 degrees) 
(3) Left lateral flexion_____  degrees  (normal: 0-45 degrees) 
(4) Right lateral flexion____  degrees  (normal: 0-45 degrees) 
(5) Left lateral rotation_____degrees  (normal: 0-80 degrees) 
(6) Right lateral rotation____degrees (normal: 0-80 degrees) 
 
 
Please check the following symptoms if the subject has them: 
Pain____, weakness____, spasm____, tenderness____, lack of endurance____  
 
